Sitemap

  1. Health Equity
    1. Schistosomiasis
      1. What is schistosomiasis?
      2. Living our commitment
        1. Water, Sanitation & Hygiene Interventions to Fight Schistosomiasis
        2. Community Engagement in WASH & Health Education
      3. What has been going on?
      4. Storytelling Lab
      5. World NTD Day
      6. Events
        1. World NTD Day 2022
      7. Our activities around World NTD Day 2021
    2. Malaria
      1. As One Against Malaria: The Programs
    3. Innovation for all
      1. Malaria
      2. Open Innovation Initiatives for Global Health
        1. Schistosomiasis Research Grant
      3. Fighting counterfeit medicines
      4. Access to clean water to fight infectious diseases
    4. Healthy Women, Healthy Economies
    5. Access to Health
      1. Sustainable Supply Chains
      2. Access to Health Pitch Competition
      3. Examples of our commitment to improving access
    6. Building Families in Asia
    7. Building Equality for Women’s Health
    8. Innovations for Child’s Health in Africa
    9. Sustainable Access Path to Fight Schistosomiasis
  2. Environment
  3. Employees
  4. Community Engagement
    1. Our Good Deeds
  5. Measuring sustainability
    1. Our tools
  6. Reports & Guidelines
  7. Our sustainability strategy
  8. Business Ethics
    1. Compliance
      1. Compliance-Hotline
    2. Human rights
      1. Our Human rights commitment
      2. How we implement the LKSG
    3. Digital Ethics
    4. Bioethics
    5. Animal Ethics
      1. Our animal facilities
      2. Rat Colony Cage
      3. Our Approach for a Roadmap to Phase out Animal Testing
    6. Sustainable supply chain
    7. Marseille Declaration on the worldwide implementation of high standards for lab animals
  9. Products & Innovation
    1. Our products: smart and green
  10. Transparency in Healthcare
    1. EFPIA HCP/HCO and R&D Reporting
    2. EFPIA Patient Organisation Reporting
    3. EFPIA HCP/HCO and R&D Reporting Downloads
  11. The Sustainables
    1. Smashing it... Sustai​nably!
    2. Meat the Future!
    3. ONE view on sustaina­bility in R&D
    4. Embracing Sustain­ability with Green Solvents
    5. Driving Decarboni­zation Together!
    6. The Patter of Tiny (Ecological) Feet
    7. Safeguar​di​ng Human Progress!
    8. Impacti​ng Soci​ety Su​stainably!
    9. Sustainab​ility... with Sub​stance!
    10. Giving healthcare a personal touch
    11. The Greener Way To Repel Disease!
    12. Sustainable By Design
  1. Media Contacts
  2. Press Kits
    1. Results of the fourth quarter and fiscal year 2024
    2. Off to a Good Start in Fiscal 2024
    3. Fiscal 2023: Proven resilience during transitional year
    4. Group Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
    5. Demonstrating Resilience under Market Pressure
    6. Group Benefits from Global Diversification in a Challenging Environment
    7. Our contributions to the fight against Covid-19
      1. A five-point plan against pandemics
      2. Updates on Covid-19
      3. How we became a manufacturer of disinfectant
      4. How the Future Insight Prize supports top scientists
      5. Global Health in times of Covid-19
      6. Face shields from a 3D printer
      7. "We need to look at every single tool we have"
      8. “We are helping to bring innovative diagnostic test kits to market”
      9. Definitive Agreement to Acquire Exelead
    8. Profitable Growth Despite Challenges
    9. Group Delivers Strong Organic Growth in Q3
    10. Q2 2022: Group Delivers Robust Growth Despite Headwinds
    11. Fiscal 2021: Record Growth and Higher Profitability
    12. Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth
    13. Strong Second Quarter with Double-Digit Growth Driven by Big 3
    14. First Quarter of 2021: Great Strength in Challenging Market Environment
    15. Lab Water Purification
    16. Access to Medicine
    17. Future Insight Prize 2019
    18. CES 2020
    19. Schistosomiasis Elimination Program
    20. Q3/2019: Financial Results
    21. Q2/2019: Merck KGaA, Darmstadt, Germany, Sees Profit Jump in Q2
    22. Q1/2019: Forecast for Organic Performance in 2019 confirmed
    23. Q4/2018: Group Achieves 2018 Targets and Is Set for Profitable Growth
    24. Financial Results 2019: Group Meets all Financial Targets
    25. Strong first quarter – low impact from Covid-19 to date
    26. Second Quarter: Group Remains on Course in a Challenging Environment
    27. Q3 2020: Strong Third Quarter
    28. CES 2021
    29. Financial Results 2020: Group Reports Record Results in a Turbulent Year
    30. Performance Materials is now Electronics
    31. Discussing future trends in Electronics at CES 2022
    32. First Quarter: Strong Start into Fiscal 2022
  3. Subscribe to News Releases
  4. Unsubscribe from News Releases
  5. Download Gallery
  1. News Blackboard
  2. 2016-01-21 Merck KGaA, Darmstadt, Germany and BrandWatch Technologies Form Long-Term Partnership
  3. 2016-01-04 Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of...
  4. 2016-04-14 Merck KGaA, Darmstadt, Germany, Appoints Maya Martinez-Davis as Global Head of Oncology
  5. 2016-04-19 MilliporeSigma Earns Accreditation for Quality Control of Culture Media
  6. 2016-02-10 Amazing Lighting Experiences with Materials from Merck KGaA, Darmstadt, Germany
  7. 2016-04-25 Merck KGaA, Darmstadt, Germany Wins European Investor Relations Awards
  8. 2016-04-26 First Multi-use Disposable Sterile Connectors for Biopharma
  9. 2016-02-19 Treasury Team Wins European Prize for Sigma-Aldrich Acquisition Financing
  10. 2016-04-29 Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Inc
  11. 2016-08-01 Merck KGaA, Darmstadt, Germany and Nanoco Sign Agreement
  12. 2016-03-02 Merck KGaA, Darmstadt, Germany, Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis
  13. 2016-08-02 Merck KGaA, Darmstadt, Germany Invests € 15 million in LC Window Technology
  14. 2016-12-01 Merck KGaA, Darmstadt, Germany Expands Distribution Agreementwith Roche
  15. 2016-04-14 Merck KGaA, Darmstadt, Germany, Responds to Legal Claims in the U.S.
  16. 2016-12-13 Merck KGaA, Darmstadt, Germany Presents Smart LCWindows at BAU 2017
  17. 2016-04-27 New MilliporeSigma Products Bring Ease of Use to Single-Use
  18. 2016-01-07 Collaboration on New Liquid Biopsy Technology
  19. 2016-07-01 Johann Heinrich Merck KGaA, Darmstadt, Germany, Award Goes To Kathrin Passig
  20. 2016-07-01 Merck KGaA, Darmstadt, Germany and University of Nairobi to Start Medical
  21. 2016-07-13 Merck KGaA, Darmstadt, Germany, Advances Water Purification Systems with New...
  22. 2016-06-29 Merck KGaA, Darmstadt, Germany, Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines
  23. 2016-07-27 Merck KGaA, Darmstadt, Germany Biopharma Innovation Cup Honors Young Scientists
  24. 2016-06-28 MilliporeSigma Expands Industry-Leading Emprove® Program
  25. 2016-06-28 MilliporeSigma to Develop Next-Generation Purification Processes with International Vaccine Institute
  26. 2016-06-07 MilliporeSigma Announces Survey Results Exploring Biopharma Industry’s Evolving
  27. 2016-07-18 MilliporeSigma Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name
  28. 2016-07-19 MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
  29. 2016-07-06 Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
  30. 2016-05-02 Merck KGaA, Darmstadt, Germany, Expands Production Know-how to Deliver Full...
  31. 2016-05-11 Merck KGaA, Darmstadt, Germany, Expands Popular Line of ...
  32. 2016-05-09 Merck KGaA, Darmstadt, Germany, Launches First Commercially Available
  33. 2016-05-10 Merck KGaA, Darmstadt, Germany, A High-Tech for the Automotive Industry
  34. 2016-05-09 Merck KGaA, Darmstadt, Germany, and Progyny Extend Collaboration for Eeva®
  35. 2016-05-04 Merck KGaA, Darmstadt, Germany, at SID: Materials for the Displays of
  36. 2016-05-04 Merck KGaA, Darmstadt, Germany, Builds on Leading Viral and Gene
  37. 2016-03-15 Photovoltaic Windows: Energy Efficient and Energy Generating
  38. 2016-03-29 Merck KGaA, Darmstadt, Germany, CRISPR Epigenetic
  39. 2016-03-07 Merck KGaA, Darmstadt, Germany, Launches Global Science Education
  40. 2016-03-08 Merck, KGaA, Darmstadt, Germany, Finishes Record Year 2015 Stronger
  41. 2016-03-07 Life Science Leader Merck KGaA, Darmstadt, Germany, Launches New Innovations
  42. 2016-11-16 Jens Frahm and Franz Pischinger Inducted into the Hall of Fame of German Research
  43. 2016-11-30 Merck KGaA, Darmstadt, Germany, Collaborates with Evotec for Faster Target Iden
  44. 2016-10-10 Merck KGaA, Darmstadt, Germany, Announces Recipients of Third Annual €1 Million ‘Grant for Oncology Innovation’ Award
  45. 2016-10-06 Merck KGaA, Darmstadt, Germany, Unveils New State-of-the-Art M Lab
  46. 2016-07-13 Merck KGaA, Darmstadt, Germany Awards Premio Letterario of Merck KGaA, Darmstadt, Germany in Rome
  47. 2016-08-03 MilliporeSigma Expands Portfolio of Certified Reference Materials
  48. 2016-08-01 MilliporeSigma to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound
  49. 2016-08-04 Merck KGaA, Darmstadt, Germany, Lifts Forecast Following Good Second Quarter
  50. 2016-08-23 Tagore Award India
  51. 2016-09-30 Merck KGaA, Darmstadt, Germany, Presents Its First Russian Literary Prize
  52. 2016-09-13 MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media
  53. 2016-09-08 MilliporeSigma Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines
  54. 2016-09-26 MilliporeSigma Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal
  55. 2016-09-19 MilliporeSigma’s New Steritest™ Symbio Pump Accessories Enable Faster, Sterility Testing in Any Setting
  56. 2016-09-07 Merck KGaA, Darmstadt, Germany, Opens New OLED Materials Production Plant in Darmstadt
  57. 2016-09-21 Merck KGaA, Darmstadt, Germany, Invests over € 50 million in Flagship Pharmaceutical Packaging Building in Darmstadt
  58. 2016-09-13 Merck KGaA, Darmstadt, Germany, Strengthens Display Materials R&D in China
  59. 2016-10-11 Merck KGaA, Darmstadt, Germany, Publishes First International Curiosity Study
  60. 2016-10-19 Merck KGaA, Darmstadt, Germany Donates 500 Millionth Praziquantel Tablet
  61. 2016-10-21 Kakehashi Literature Prize Presented in Japan
  62. 2016-10-05 MilliporeSigma’s Udit Batra Receives CPhI’s ‘CEO of the Year’ Award
  63. 2016-10-28 Merck KGaA, Darmstadt, Germany, Named as Top Employer by Science Magazine
  64. 2016-11-11 MilliporeSigma Wins R&D 100 Award for Top Invention
  65. 2016-11-04 Merck KGaA, Darmstadt, Germany, Invests € 250 Million in Production Value Chain in China
  66. 2016-11-22 Frosty-brilliant Silver Shine: The Merck KGaA, Darmstadt, Germany, Pigment Innovation Ronastar® Frozen Jewel
  67. 2016-10-18 Merck KGaA, Darmstadt, Germany, Showcases Innovative Effect Pigments and Processes at K2016
  68. 2016-11-15 Merck KGaA, Darmstadt, Germany, Raises Profit Forecast for 2016 Following Good Third Quarter
  69. 2016-12-05 MilliporeSigma to Provide Provantage® End-to-End Services to Acticor Biotech SAS
  70. 2016-12-08 Merck KGaA, Darmstadt, Germany, Appoints Thomas Möller as new Head of External Communications
  71. 2016-12-02 MilliporeSigma Launches Parteck® MXP Excipient for Increased Solubility
  72. 2016-10-13 MilliporeSigma Introduces First Certified Spiking Solution® of Heavy Labeled
  73. 2016-09-28 Merck KGaA, Darmstadt, Germany, to Present New Research Focused on Hard-to
  74. 2016-09-22 Merck KGaA, Darmstadt, Germany, and the Royal Health Awareness Society Partner
  75. 2016-09-08 Merck KGaA, Darmstadt, Germany, is Co-Creating the Cars of Tomorrow
  76. 2017-01-10 Merck KGaA, Darmstadt, Germany and CLEARink Displays Sign Development Agreement
  77. 2016-02-15 Merck KGaA, Darmstadt, Germany Presents New Material Advancements for Next Generation Lithography
  78. 2016-06-09 Accelerator Program of Merck KGaA, Darmstadt, Germany, Expands its Reach to Silicon Valley
  79. 2016-05-18 Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
  80. 2016-10-06 Merck KGaA, Darmstadt, Germany, Defines Blue-Glow Purple as the Effect Color of 2017
  81. 2016-04-29 Merck KGaA, Darmstadt, Germany, Annual General Meeting 2016: CEO Handover After Ten Successful Years
  82. 2016-11-07 Merck KGaA, Darmstadt, Germany and Idemitsu Signed Collaboration Agreement in the OLED Material Business
  83. 2016-04-14 Merck KGaA, Darmstadt, Germany, to Present Data On Comparative Effectiveness of Rebif® versus Oral Therapy at AAN Annual Meeting
  84. 2016-07-15 Dietmar Eidens Appointed Chief HR Officer (CHRO) of Merck KGaA, Darmstadt, Germany
  85. 2016-09-22 Merck KGaA, Darmstadt, Germany, Presents Displaying Futures Award for the First Time
  86. 2016-09-16 Merck KGaA, Darmstadt, Germany, Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis
  87. 2016-10-31 European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
  88. 2016-04-05 Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
  89. 2017-01-10 MilliporeSigma Expands End-to-End Biodevelopment Centers in North America,
  90. 2016-11-14 Merck KGaA, Darmstadt, Germany Ranks Fourth in 2016 Access to Medicine Index
  91. 2016-10-13 Merck KGaA, Darmstadt, Germany, Sets its Sights on 2018 and Outlines Future Strategic Roadmap
  92. 2017-01-18 MilliporeSigma Launches First Commercial Service to Predict Multiple Sources of
  93. 2016-06-01 Merck KGaA, Darmstadt, Germany: Belén Garijo Receives Prestigious Career Award
  94. 2017-01-17 MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain
  95. 2016-09-15 "From Glitter to Glamour" – The Merck KGaA’s, Darmstadt, Germany, Pigment Innovation Ronastar® Royal Sparkle
  96. 2016-05-24 Merck KGaA, Darmstadt, Germany, Showcases Innovative Effect Pigments and Printing Technologies at Drupa 2016
  97. 2017-01-12 Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration
  98. 2016-05-30 For perfect white – Iriodin® 6111 Icy White Pristine KU26 from Merck KGaA, Darmstadt, Germany
  99. 2016-09-23 Merck KGaA, Darmstadt, Germany, Appoints Isabel De Paoli as Chief Strategy Officer
  100. 2016-07-18 Merck KGaA, Darmstadt, Germany, Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets
  101. 2016-09-15 Merck KGaA, Darmstadt, Germany, Announces 2016 Recipients of €1 Million Grant for Multiple Sclerosis Innovation
  102. 2016-09-12 Merck KGaA, Darmstadt, Germany, Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress
  103. 2017-01-19 Innovation Award for Organic Photovoltaics at the BAU 2017
  104. 2017-01-17 Merck KGaA, Darmstadt, Germany, Moves Executives Between Businesses
  105. 2016-01-19 Merck KGaA, Darmstadt, Germany, Appoints New Executive Board Members
  106. 2016-03-29 Merck KGaA, Darmstadt, Germany, Presents New Highlights at In-Cosmetics 2016: Make-up Trends, Innovative Protection and Personal Care Concepts
  107. 2016-07-08 Merck KGaA, Darmstadt, Germany, Launches New High-Temperature Pigment Series for the Ceramics Industry
  108. 2016-06-30 Merck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
  109. 2017-01-12 Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S. to Fo
  110. 2016-11-02 Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at the 2016 ACR/ARHP Annual Meeting
  111. 2016-11-14 Merck KGaA, Darmstadt, Germany Confirm Potential of Atacicept
  112. 2016-06-06 ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
  113. 2016-10-12 Plastics with 3D Effect: Merck KGaA, Darmstadt, Germany and PolyOne Agree to Collaborate
  114. 2016-09-12 Merck KGaA, Darmstadt, Germany Announces Recipients of the Grant for Growth Innovation 2016
  115. 2016-12-05 Ronastar® Red Allure: The elegant, matte pigment innovation from Merck KGaA, Darmstadt, Germany
  116. 2016-12-15 Xirallic® NXT Cougar Red: The mysterious colorintense pigment innovation from Merck KGaA, Darmstadt, Germany
  117. 2017-01-12 Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S.
  118. 2017-01-11 Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development
  119. 2017-02-28 FDA Accepts the Biologics License Application for Avelumab for the Treatment...
  120. 2017-02-09 Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with...
  121. 2017-02-02 Merck KGaA, Darmstadt, Germany, appoints Anke Schenkel as Head of Group Control
  122. 2017-03-02 Allergopharma Opens new Biopharmaceutical Production in Reinbek
  123. 2017-03-30Merck KGaA, Darmstadt, Germany Advances R&D Strategy through Unique Development
  124. 2017-03-23 FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved
  125. 2017-03-22 “Bold & Vibrant”: Merck KGaA, Darmstadt, Germany, Presents Innovations at the E
  126. 2017-03-09 Merck KGaA, Darmstadt, Germany, Generates Record Sales and Continues to Grow Pr
  127. 2017-03-16 Merck KGaA, Darmstadt, Germany, Presents Special Effect Products and Concepts a
  128. 2017-04-24 Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius
  129. 2017-04-12 EU Horizon 2020 Project “HyperOLED” Successfully Launched
  130. 2016-05-19 Merck KGaA, Darmstadt, Germany, Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
  131. 2016-06-08 Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
  132. 2016-11-14 MilliporeSigma Launches Next-Generation Technology for Advanced Live Cell Imaging
  133. 2017-01-04 MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testin
  134. 2017-03-06 MilliporeSigma Advances Lab Water Purification Technology with Milli-Q® IQ 7000
  135. 2017-04-06 New Full Spectrum (FS) Phosphors: Merck KGaA, Darmstadt, Germany, Presents Bran
  136. 2017-04-18 Merck KGaA, Darmstadt, Germany Furthers Commitment Towards Elimination of Schis
  137. 2016-01-27 Merck KGaA, Darmstadt, Germany, Announces New Biopharma Heads for North America
  138. 2016-02-16 Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
  139. 2016-02-16 Merck KGaA, Darmstadt, Germany, and Weizmann Institute Sign New Framework Agree
  140. 2016-03-03 Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial
  141. 2016-05-24 Nigeria Receives Record Praziquantel Donation
  142. 2016-07-08 Your Merck KGaA, Darmstadt, Germany, news subscription: Chemicals is now Life S
  143. 2016-11-01 Merck KGaA, Darmstadt, Germany, Partners with American Cancer Society to Addres
  144. 2016-01-15 Merck KGaA, Darmstadt, Germany Announces Favorable UK Court Ruling on Name Use
  145. 2016-10-17 Merck KGaA, Darmstadt, Germany, Expands Biotech Production Capacity in Spain
  146. 2016-12-16 MilliporeSigma Wins Life Science Industry Award® for Most Memorable Advertising
  147. 2016-08-03 MilliporeSigma Expands Portfolio of Certified Reference Materials for Applied
  148. 2016-12-02 MilliporeSigma Introduces MILLIPLEX® High Sensitivity Panel for Faster, More
  149. 2016-07-12 MilliporeSigma Expands Excipients Portfolio, Adding Polymers for Sustained Rele
  150. 2016-06-08 Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
  151. 2016-06-28 MilliporeSigma Expands Industry-Leading Emprove® Program to Include Filtration
  152. 2016-03-21 MilliporeSigma Introduces IsoBag™ for Faster and Easier Transfer of Contact and
  153. 2016-11-14 Merck KGaA, Darmstadt, Germany’s Phase IIb ADDRESS II Results Confirm Potential
  154. 2016-09-14 Merck KGaA, Darmstadt, Germany, Joins DiViNe Consortium to Address Low Yields,
  155. 2016-09-13 MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media
  156. 2016-11-29 FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
  157. 2016-10-17 Merck KGaA, Darmstadt, Germany, Expands Biotech Production Capacity in Spain
  158. 2017-06-04 Merck KGaA, Darmstadt, Germany Strengthens Immuno-Oncology Portfolio through Expansion of Fstar Collaboration including LAG-3/PD-L1 Bispecific Antibody
  159. 2017-04-28 We are a company driven by a passion for research and discovery
  160. 2017-04-28 Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Increase
  161. 2017-05-09 MilliporeSigma Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering
  162. 2017-05-17 Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017
  163. 2017-05-17 MilliporeSigma Develops Alternative CRISPR Genome Editing Method
  164. 2017-05-17 Shaping Cancer Care Today and Tomorrow: Merck, KGaA, Darmstadt, Germany, to Present New Data from Rapidly Evolving Pipeline at ASCO 2017
  165. 2017-05-09 FDA Grants Bavencio® approval for a common type of advanced bladder cancer
  166. 2017-05-16 MilliporeSigma’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune
  167. 2017-05-31 Anyone Can Become More Curious. Is That True?
  168. 2017-05-12 MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India
  169. 2017-05-16 Optimizing the Further Development of the Darmstadt Site
  170. 2017-05-15 MilliporeSigma Launches Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes
  171. 2017-05-18 Liquid Crystals for New Optical Applications: Collaboration with the University of Leeds
  172. 2017-05-02 Merck KGaA, Darmstadt, Germany, and Schmid Rhyner AG cooperate on 3D technology for printing with depth effect
  173. 2017-05-08 Merck KGaA, Darmstadt, Germany, at SID: Future-oriented Materials for Displays and More
  174. 2017-01-23 Merck KGaA, Darmstadt, Germany, Announces Research Collaboration with Domain Th
  175. 2017-06-14 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office
  176. 2017-06-15 Expand Distribution Agreement with Public Health England
  177. 2017-06-20 Our Company Creates New Immuno-Oncology Company iOnctura
  178. 2017-06-22 Pigment Innovation at the Laser World of Photonics 2017
  179. 2017-06-23 Cladribine Tablets Receives Positive CHMP Opinion
  180. 2017-06-26 Displaying Futures Award Attracts High Interest
  181. 2017-06-26 MilliporeSigma adds Chemical Products to Reaxys’ Chemistry Database
  182. 2017-06-29 Our company and Industry Partners Create New Automotive Coating Effects
  183. 2017-07-06 Merck KGaA, Darmstadt, Germany, Biopharma Innovation Cup 2017
  184. 2017-07-05 Our Company Awards its 2017 Grant for Fertility Innovation (GFI)
  185. 2017-04-25 MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups
  186. 2017-05-01 MilliporeSigma’s Mobius® 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities
  187. 2017-05-18 Merck KGaA, Darmstadt, Germany, Continues to Grow Profitably in the First Quarter
  188. 2017-07-06 Response on European Commission Statement of Objections
  189. 2017-07-12 Our company Refines Western European Life Science Production Site Network
  190. 2017-07-21 New Application Laboratory in Shanghai
  191. 2017-07-21 Avelumab
  192. 2017-08-03 Second-quarter results 2017
  193. 2017-08-03 European Patent Office to Grant Merck KGaA, Darmstadt, Germany’s Patent
  194. 2017-08-03 Executive Board Changes at Merck KGaA, Darmstadt, Germany
  195. 2017-08-03 Advance Vaccine Development and Manufacturing for Neglected Diseases
  196. 2017-08-25 Mavenclad
  197. 2017-08-23 Merck KGaA, Darmstadt, Germany to Exhibit at the IAA for the First Time
  198. 2017-08-23 Merck KGaA, Darmstadt, Germany Sets Up PMatX Incubator in Israel
  199. 2017-08-31 Seoul-Biennale
  200. 2017-08-31 ESMO 2017
  201. 2017-09-01-HEM-Award-2017
  202. 2017-09-01 Successful Closing of Biosimilars Transaction
  203. 2017-09-05 Merck KGaA, Darmstadt, Germany, Prepares Strategic Options for the CH
  204. 2017-09-07-IAA
  205. 2017-09-11 GOI Awards ESMO 2017
  206. 2017-09-11 PM-A new head names Heidi Fagerholm
  207. 2017-09-11 GOBDA-MOU-signin
  208. 2017-09-12 Merck KGaA, Darmstadt, Germany, Advances Immunology Pipeline with Evobrutinib
  209. 2017-09-14 IAA-Successful-Premiere
  210. 2017-09-18 Recipients of the Grant for Growth Innovation 2017
  211. 2017-09-21 Bavencio EC Approval
  212. 2017-09-21 ISAL-Automotive-Lighting
  213. 2017-09-25 Investors-Darling
  214. 2017-09-27 Bavencio-Japan-Approval
  215. 2017-09-28 Capital Markets Day 2017
  216. 2017-10-03 Merck KGaA, Darmstadt, Germany, invests € 35 Million in site of Bari
  217. 2017-10-05 Global Initiative
  218. 2017-10-11 New Life Science Center Burlington
  219. 2017-10-17 Merck KGaA, Darmstadt, Germany Presents New Clinical Data at ACR Annual Meeting
  220. 2017-10-19 Carlsbad
  221. 2017-10-20 Advanced Light Protection Award
  222. 2017-10-20 Science Top Employer
  223. 2017-10-24 Crispr Canada Patent
  224. 2017-10-26 ECTRIMS 2017
  225. 2017-10-25 LC-Windows-Frost-Sullivan-Award
  226. 2017-10-25 MS-in-Women-Report-Announcement
  227. 2017-11-01 Lupus Foundation of America collaboration with Merck KGaA, Darmstadt, Germany
  228. 2017-11-04 Late Breaking Clinical Data from Phase II Trial of Sprifermin
  229. 2017-11-09 Third quarter of 2017
  230. 2017-11-09 NICE Recommends Mavenclad
  231. 2017-11-09 Displaying-Futures-Tokyo
  232. 2017-11-17 Top Place to Work
  233. 2017-11-28 JAVELIN Gastric 300 Study
  234. 2017-11-30 Merck KGaA, Darmstadt, Germany, Opens Production Facility
  235. 2017-12-04 Cladribine Approved for Relapsing-Remitting MS in Canada
  236. 2017-12-05 Fertility Benchtop Incubator GeriTM
  237. 2017-12-07 Mavenclad Approval Australia
  238. 2015-01-15 News Archive 2015
  239. 2017-12-12 Allan Gabor Takes Over Leadership in China
  240. 2017-12-13 New Partnership to Fight Schistosomiasis
  241. 2017-12-15 Corporate Affairs Wicklandt
  242. 2017-12-19 Singapore’s IP Office to Grant Milli’s Patent Application for CRISPR Technology
  243. 2017-12-21 Avelumab Breakthrough Designation RCC
  244. 2017-12-20 Collaboration with iCON™
  245. 2014-01-15 News Archive 2014
  246. 2013-01-15 Press Releases before 2014
  247. 2012-01-15 Press Releases before 2014
  248. 2011-01-15 Press Releases before 2014
  249. 2010-01-15 Press Releases before 2014
  250. 2009-01-15 Press Releases before 2014
  251. 2008-01-15 Press Releases before 2014
  252. 2018-01-16 ASCO GI Curtain Raiser
  253. 2018-01-26 New Chief Information Officer
  254. 2018-02-01 Researching New Highly Efficient OLEDs with Quantum Materials
  255. 2018-02-05 350th Anniversary
  256. 2018-02-05 Displaying-Futures-Award
  257. 2018-02-08 Merck KGaA, Darmstadt, Germany Plans 350 Good Deeds for its Anniversary Year
  258. 2018-02-13 MilliporeSigma Launches Viresolve® Barrier Capsule Filters
  259. 2018-02-15 Update on Phase III JAVELIN Lung
  260. 2018-02-16 Merck KGaA, Darmstadt, Germany, Named One of the Global Top Employers in 2018
  261. 2018-02-20 ExploreBio
  262. 2018-02-21 40 mn investment Asia
  263. 2018-02-22 Nine new signature partnerships
  264. 2018-02-28 Expanded Seeding Labs Part
  265. 2018-02-26 MAVENCLAD receives first approval in Latin America
  266. 2018-03-06-Evobrutinib in Relapsing Multiple Sclerosis
  267. 2018-03-08 Q4-FY Results of 2017
  268. 2018-03-13 Changes to Performance Materials Leadership Team
  269. 2018-03-19 Merck KGaA, Darmstadt, Germany Lights up Luminale 2018 in Frankfurt
  270. 2018-04-09 Mavenclad Receives First Approval in the Middle East & African Region
  271. 2018-03-27 Medisafe partnership
  272. 2018-03-27 Fast-Track Designation for Tepotinib
  273. 2018-04-12 MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines
  274. 2018-04-13 Advance Multiple Sclerosis Treatment with MAVENCLAD and REBIF Data at AAN 2018
  275. 2018-04-17 new single use technologies to advance flexible manufacturing
  276. 2018-04-17 OARSI Curtain Raiser
  277. 2018-04-18 MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation
  278. 2018-04-19 Consumer Health Divestiture
  279. 2018-04-19 Partnership-UCT-MMV
  280. 2018-04-23 Patent for CRISPR technology in China
  281. 2018-04-27 MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer
  282. 2018-04-27 Annual General Meeting 2018
  283. 2018-04-27 Annual General Meeting 2018 Part 2
  284. 2018-05-02 Cladribine Tablets Data in MS Journal Show a Strong Treatment Effect
  285. 2018-05-02 Corporate Responsibility Report Documents Comprehensive Engagement
  286. 2018-05-02 Merck KGaA, Darmstadt, Germany to Develop Abituzumab
  287. 2018-05-03 Ceremony 350
  288. 2018-05-14 New Liquid Crystal Singles by Merck KGaA, Darmstadt, Germany on the SID 2018
  289. 2018-05-15 Q1 - 2018
  290. 2018-05-16 MilliporeSigma to Use Genome Editing in Study of Gut Bacteria
  291. 2018-05-29 MilliporeSigma Announces Collaboration with Solvias
  292. 2018-05-16 Merck KGaA, Darmstadt, Germany, data at ASCO 2018 to showcase progress
  293. 2018-05-22 Merck KGaA, Darmstadt, Germany, Survey Reveals Most Thyroid Disorder Patients
  294. 2018-05-22 Merck KGaA, Darmstadt, Germany, Ignites Firework of Research Initiatives
  295. 2018-05-30 World MS Day 2018: Call for Greater Curiosity to Drive Understanding of the Disease and Future Innovation
  296. 2018-06-03 Merck KGaA, Darmstadt, Germany Presents Update on Tepotinib
  297. 2018-06-04 Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for M7824
  298. 2018-06-04 Update Javelin Merkel 200 Bavencio
  299. 2018-06-05 Bringing Biotechs Closer
  300. 2018-06-06 Final Registration REACH
  301. 2018-06-06 Merck KGaA, Darmstadt, Germany, Enhances Research in Ghana
  302. 2018-06-11 Update on Tepotinib Phase II Results
  303. 2018-06-12 Thought Leadership in Ethical Gene Editing
  304. 2018-06-12-Merck KGaA, Darmstadt, Germany Selects Three Winning Teams for Displaying Futur
  305. 2018-05-28 Digital Color Card App: Effect Pigments Go Digital
  306. 2018-06-14 Data on Investigational Cladribine Tablets and Rebif® in RMS
  307. 2018-06-18 Further Insight into the Efficacy of Investigational Cladribine Tablets
  308. 2018-06-19 Agreement with HistoCyte Laboratories
  309. 2018-06-20 China Celebration 350
  310. 2018-06-20 OLED Lab China
  311. 2018-07-03 Performance Materials Strategy Update
  312. 2018-07-17 Merck KGaA, Darmstadt, Germany, Announces Future Insight Prize
  313. 2018-07-26 Merck KGaA, Darmstadt, Germany receives recommendation for approval in 21 EU co
  314. 2018-07-26 MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with
  315. 2018-07-30 CladribineTablets FDA filing acceptance
  316. 2018-08-09 Q2 - 2018
  317. 2018-08-09 GL Changes
  318. 2018-08-15 Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent
  319. 2018-09-04 MilliporeSigma Launches Next-Generation Process Technologies for Intensified Dr
  320. 2018-09-03 Ronastar® Black Allure: Merck KGaA, Darmstadt, Germany, introduces the next new
  321. 2018-09-10 New Application Labs in Philadelphia Enable Close Collaboration
  322. 2018-09-11 Positive Phase-III-Studie Bavencio plus Inlyta
  323. 2018-09-14 Merck KGaA, Darmstadt, Germany, Presents Interdisciplinary Cosmetics Research a
  324. 2018-09-21 MilliporeSigma Makes Major Investment in New Singapore Laboratory
  325. 2018-10-02 MilliporeSigma Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for
  326. 04-10-2018 MilliporeSigma Opens M Lab™ Collaboration Center in São Paulo, Brazil
  327. 2018-10-08 New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018
  328. 2018-10-11 Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosi
  329. 2018-10-09 ESMO Curtain Raiser
  330. 2018-10-10 Up to 10-Years of Follow-up Data Reaffirm Safety Profile of Investigational Cla
  331. 2018-10-12 MilliporeSigma Recognized with CPhI Awards for Innovative Products
  332. 2018-10-12 Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy
  333. 2018-10-16-Merck KGaA, Darmstadt, Germany, Aims to Return to Profitable Growth as of 2019
  334. 2018-10-17 Merck KGaA, Darmstadt, Germany Inaugurates State-of-the-art Pharma Packaging Ce
  335. 2018-10-18 MilliporeSigma Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Tec
  336. 2018-10-22 Merck KGaA, Darmstadt, Germany, Presents Updated Results for Bifunctional Immun
  337. 2018-10-23 Merck KGaA, Darmstadt, Germany unveils new product brand eyrise™
  338. 2018-10-30 Merck KGaA, Darmstadt, Germany, Presents First Curious Mind Researcher Award
  339. 2018-11-05 MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Impr
  340. 2018-11-05 Embracing Carers™ expands support for caregivers worldwide
  341. 2018-11-06 Merck KGaA, Darmstadt, Germany Debuts at First China International Import Expo
  342. 2018-11-12 Merck KGaA, Darmstadt, Germany, Paves the Way for its Innovation Hub in Souther
  343. 2018-11-14 Q3 - 2018
  344. 2018-11-19 JAVELIN Ovarian 200
  345. 2018-11-19 Syntropy
  346. 2018-11-20 Access to Medicine Index 2018
  347. 2018-11-23 MVentures
  348. 2018-11-23 Change II at ESMO Asia
  349. 2018-11-27 MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018
  350. 2018-11-28 Euroshareholders Award 2018
  351. 2018-12-01 Merck KGaA, Darmstadt, Germany, successfully divests Consumer Health
  352. 2016-08-23 Wenzel to Lead the Surface Solutions
  353. 2018-12-03 Merck KGaA, Darmstadt, Germany Marks Fifth Anniversary of MDM Shanghai
  354. 2018-12-06 Merck KGaA, Darmstadt, Germany, in Agreement with Cyclica for AI-augmented Scre
  355. 2018-12-06 Performance Materials Enables Innovations
  356. 2018-12-10 CRISPR strategic Alliance
  357. 2018-12-10-Merck KGaA, Darmstadt, Germany, Announces FDA Orphan Drug Designation
  358. 2018-12-13 Merck KGaA, Darmstadt, Germany, to Showcase Innovative Architectural Solutions
  359. 2018-12-21 Price Increase Surface Solutions
  360. 2018-12-20 Intrexon
  361. 2018-12-20 Kuraray collaboration
  362. 2018-12-20 M7824 ODD EMA
  363. 2018-12-21 JAVELIN Ovarian 100
  364. 2019-01-15 Best Social Media Award
  365. 2019-01-16 Merck KGaA, Darmstadt, Germany, Welcomes Ten New Startups
  366. 2019-01-23 Tencent Partnership China
  367. 2019-01-24 Vertex DNA PK Licensing
  368. 2019-01-28 EM-Boards
  369. 2019-01-30 US Patent Blockchain
  370. 2019-02-04 MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular
  371. 2019-02-01 Ecovadis-Rating
  372. 2019-02-05-m7824
  373. 2019-02-06 Merck KGaA, Darmstadt, Germany, Named a Global Top Employer
  374. 2019-02-06 Merck KGaA, Darmstadt, Germany to Expand US Biopharmaceutical R&D Facility
  375. 2019-02-11 Bavencio-Inlyta-FDA-sBLA
  376. 2019-02-16 ASCO
  377. 2019-02-19 First U.S. Patent for Improved CRISPR Genome-Editing Method
  378. 2019-04-24 MilliporeSigma Introduces New Greener Solvent, Cyrene™
  379. 2019-02-25 Merck KGaA, Darmstadt, Germany at in-cosmetics 2019
  380. 2019-02-27 Science and Skincare Industry Meet at 4th DermoCosmetics Foru
  381. 2019-02-27 Versum
  382. 2019-03-04 MilliporeSigma Awarded Canadian CRISPR Nickase Patent
  383. 2019-03-07 Q4/FY Results of 2018
  384. 2019-03-05 Versum Open Letter
  385. 2019-03-08 European Medicines Agency Validates Application for BAVENCIO® Plus INLYTA®
  386. 2019-03-12 Versum Preliminary Proxy Statement
  387. 2019-03-18 MilliporeSigma- Milli-Q® Connect-Water Purification with Cloud-based Technology
  388. 2019-03-14 Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology
  389. 2019-03-19 Collaboration GenScript China
  390. 2019-03-20 First M-Lab Collaboration Center in Europe
  391. 2019-03-19 JAVELIN Ovarian PARP
  392. 2019-03-20 Agreement applicable to the Darmstadt site
  393. 2019-03-25 First Short-Course Oral Treatment for RRMS in Switzerland
  394. 2019-03-26 Versum
  395. 2019-03-28 Merck KGaA, Darmstadt, Germany, Expansion of Capacity for Biotech Medicines
  396. 2019-03-29 Mavenclad
  397. 2019-04-04 MilliporeSigma Recognized with INTERPHEX Exhibitor Award for Best New Product
  398. 2019-04-15 Merck KGaA, Darmstadt, Germany Publishes Corporate Responsibility Report 2018
  399. 2019-04-12 Versum Definitive Agreement
  400. 2019-04-26 Wolfgang Büchele Re-elected Supervisory Board Chairman
  401. 2019-04-26 Merck KGaA, Darmstadt, Germany, Presents Plans for Future Growth to Shareholders
  402. 2019-04-30 Mavenclad
  403. 2019-05-02 ESA
  404. 2019-05-14 Bavencio
  405. 2019-05-06 IMI
  406. 2019-05-10-PPII-Data-Further-Highlights-Clinical-Proof-of-Concept-for-Evobrutinib
  407. 2019-05-14 Q1-2019
  408. 2019-05-15 ASCO 2019
  409. 2019-05-20 MilliporeSigma Joins TRANSVAC2 to Advance Vaccine Development and Manufacturing
  410. 2019-05-22 WHA Life Science
  411. 2019-05-28-pm-sandmann-weiland
  412. 2019-05-30-Pioneers-New-Effort-to-See-MS-from-the-Inside-Out
  413. 2019-05-30 MilliporeSigma Awards Grants to Biotechs
  414. 2019-06-03 Updated Results for Investigational Therapy Tepotinib
  415. 2019-06-06 Crystal Do
  416. 2019-06-04 Quantum Computing
  417. 2019-06-05 Accelerator
  418. 2019-06-17 Versum Stockholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
  419. 2019-06-18 Bond Financing Rating
  420. 2019-06-20 Best Places to Work
  421. 2019-06-24 Mavenclad
  422. 2019-07-01 Merck KGaA, Darmstadt, Germany Places Bonds Amounting to € 2 Billion
  423. 2019-07-09 Future Insight Prize
  424. 2019-07-16 Embracing Carers Time Counts
  425. 2019-07-18 Intermolecular
  426. 2019-07-18 Broad Institute
  427. 2019-08-05 UDC PR
  428. 2019-08-08-Q2-2019
  429. 2019-08-06 MilliporeSigma Acquires BSSN Software to Accelerate Digital Transformation
  430. 2019-08-19-crispr-patents
  431. 2019-08-28-ECTRIMS
  432. 2019-09-04-Heinrich-Emanuel-Merck-Award-2019
  433. 2019-09-09 WCLC 2019 Tepotinib
  434. 2019-09-10-Evobrutinib
  435. 2019-09-11 Capital Markets Day 2019
  436. 2019-09-11 Tepotinib Breakthrough Therapy Designation
  437. 2019-09-11 Capital Markets Day 2019 Update
  438. 2019-09-20 Intermolecular
  439. 2019-09-23-Rebif-label
  440. 2019-09-20 Bavencio-RCC-CHMP
  441. 2019-09-23 ESMO19 Curtain Raiser
  442. 2019-09-24 Women with Cancer
  443. 2019-10-08 Merck KGaA, Darmstadt, Germany, Expands and Modernizes Pigments Production
  444. 2019-09-27 ESMO Bavencio
  445. 2019-09-27 Erbitux 1L Approval in China
  446. 2019-10-04 Schistosomiasis
  447. 2019-10-07 Pigment Innovations at K2019
  448. 2019-10-08 JAMA Publication of Phase II Results of Sprifermin
  449. 2019-10-07 Versum Closing
  450. 2019-10-10 MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy
  451. 2019-10-18 Innovation Center Shanghai
  452. 2019-10-22 Bavencio-MCC
  453. 2019-10-28 Bavencio-RCC-EC-Approval
  454. 2019-10-29-Curious Mind Researcher Award Granted
  455. 2019-11-12 MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
  456. 2019-11-08 Bavencio Update JavelinGastric100
  457. 2019-11-14 Merck KGaA, Darmstadt, Germany, Generates Profitable Growth in Q3 2019
  458. 2019-11-18 MilliporeSigma Wins R&D 100 Award for First-to-Market Biopharma Purification
  459. 2019-11-20 Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investiga
  460. 2019-11-26 Japan and Singapore Grant CRISPR Patents to MilliporeSigma
  461. 2019-12-16 Consumer Electronics Show 2020
  462. 2019-12-19 CRISPR license to Promega
  463. 2020-01-06 Bavencio Bladder 100
  464. 2020-01-09 Bonds
  465. 2020-01-27 Our company invest in State-Of-The-Art Biotech Development Facility
  466. 01-30-2020 Merck KGaA, Darmstadt, Germany Donates one Billionth Praziquantel Tablet
  467. 2020-02-11 MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
  468. 2020-02-18 MilliporeSigma to Manufacture Elypta’s Liquid Biopsy Kits
  469. 2020-02-19 Allergopharma
  470. 2020-02-27 3D Printing of Tablets
  471. 2020-03-03 MilliporeSigma’s New LANEXO™ System to Improve Lab Productivity
  472. 2020-03-05 Q4 2019
  473. 2020-03-13 Bavencio Head and Neck
  474. 2020-03-16 Ronastar® Dazzling Lights – new pigment by Merck KGaA, Darmstadt, Germany
  475. 2020-03-16 AGM Announcement
  476. 2020-03-18 Clinicaltrials Update Company Statement
  477. Merck KGaA, Darmstadt, Germany, statement on Rebif (interferon beta-1a) donation to INSERM
  478. 2020-03-25 Tepotinib
  479. 2020-03-27 RonaCare<sup>®</sup> Balmance Restores Harmony to the Skin
  480. 2020-03-31 Allergopharma Closing
  481. HC company statement
  482. Merck KGaA, Darmstadt, Germany, donates 150,000 Liters of Disinfectant
  483. 2020-04-07 Second U.S. Patent for CRISPR Gene-Editing Technology
  484. Merck KGaA, Darmstadt, Germany statement on Rebif® donation to the WHO
  485. 2020-04-09 1L UC Submission and BTD
  486. Merck KGaA, Darmstadt, Germany Announces its Support of Jenner Institute Reaching first...
  487. Merck KGaA, Darmstadt, Germany, is Supporting Darmstadt in the COVID-19 Crisis
  488. 2020-04-21 Boost to Commercial Viral Vector and Gene Therapy Manufacturing Capacity
  489. 2020-04-23 Ronastar<sup>®</sup> Blue Lights – new interference pigment
  490. 2020-04-24 Merck KGaA, Darmstadt, Germany, Acquires OLED Patents for Display Applications
  491. Merck KGaA, Darmstadt, Germany, To Hold Virtual Annual General Meeting On May 28
  492. 2020-04-30 MilliporeSigma Accelerates Readiness of Bioprocessing Facility of the Future
  493. ASCO 2020 Curtain Raiser
  494. Q1/2020: Quarterly Statement
  495. China Seed Fund Investment
  496. Merck KGaA, Darmstadt, Germany Granted U.S. Patents for CRISPR-Cas9 Technology
  497. Masks-Donation
  498. ASCO 2020
  499. New Late Breaking Data at EAN Evobrutinib
  500. Joined Forces on World MS Day
  501. Merck KGaA, Darmstadt, Germany, and Baylor College of Medicine Collaboration
  502. AGM 2020 - Annual General Meeting Approves Dividend Proposal
  503. New England Journal of Medicine Publishes Primary Analysis of VISION Data for Tepotinib
  504. 2020-06-02 Merck KGaA, Darmstadt, Germany, Announces Performance Materials Organization
  505. 2020-06-03 Merck KGaA, Darmstadt, Germany announced its second “Live Cosmetics Conference”
  506. Strategic Partnership with Guardian Glass
  507. Powerful New Option for CRISPR Research
  508. European Medicines Agency Validates Application for BAVENCIO® (avelumab)
  509. Startup from Innovation Lab Markets First Predictive Maintenance Sensors
  510. First Clinical Trial of TLR7 and 8 Inhibitor as a Potential Treatment for Severe Symptoms
  511. FDA Approves BAVENCIO® (avelumab) as First-Line Maintenance Treatment for Patients
  512. EU-Commission Supplementary Statement of Objections
  513. AI development with Janssen
  514. 2020-07-01 MilliporeSigma Advances Bioprocessing with Raman Technology Sensor Acquisition
  515. New Report Identifies Paths to Pandemic Resilience
  516. 2020-07-06 MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech
  517. Changes Executive Board
  518. Opening of Life Science Business’ Largest M Lab™ Collaboration Center in Shanghai
  519. Stephan Sieber awarded € 1 million Future Insight Prize 2020
  520. MilliporeSigma Invests $20 Million in New Switzerland Laboratory
  521. Performance Materials Launches € 100,000 Community Involvement Initiative
  522. MilliporeSigma’s DOZN™ Green Chemistry Tool Named Top Project of the Year
  523. Bavencio-UK-NICE
  524. Statement on Rebif® (interferon beta-1a) contribution to the US National Institute of Allergy and Infectious Diseases for the ACTT 3 trial
  525. Second Quarter: Group Remains on Course in a Challenging Environment
  526. Tepotinib File Acceptance FDA 25-08-2020
  527. Hybrid 2020
  528. New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting
  529. Merck KGaA, Darmstadt, Germany Announces € 59 Million ADC Manufacturing Expansion
  530. Positive Phase II Results for Investigational Sonelokimab (M1095)
  531. ESMO 2020 Curtain Raiser
  532. Merck KGaA, Darmstadt, Germany, Well-Positioned for Further Growth
  533. Bavencio-Bladder-100-NEJM-ESMO
  534. Merck KGaA, Darmstadt, Germany, Opens State-of-the-art Research Center
  535. Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021
  536. Press Release Supplementing Ad-hoc Announcement of September 29, 2020
  537. Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis
  538. Merck KGaA, Darmstadt, Germany Celebrates for New Membrane Production Facility
  539. MilliporeSigma Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara
  540. New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies
  541. Healthcare R&D Leadership
  542. MilliporeSigma Awards Grant to Combined Therapeutics
  543. Curious Mind Research Award 2020
  544. 2020-10-28 Merck KGaA, Darmstadt, Germany, Announces € 20 Million OLED Manufacturing Expan
  545. 2020-10-29 MilliporeSigma Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Te
  546. 2020-11-06 Merck KGaA, Darmstadt, Germany, Plans to Build a New Electronics Technology Cen
  547. MilliporeSigma’s Latest Technologies Earn Industry Recognition for Accelerating
  548. Merck KGaA, Darmstadt, Germany, Announces Out-Licensing Agreement
  549. Merck KGaA, Darmstadt, Germany, Reports Strong Third Quarter
  550. Merck KGaA, Darmstadt, Germany, Presents New Sustainability Strategy
  551. Ronastar® Yellow Allure – New Mass Tone pigment for Matte and Luminous Elegancy
  552. Tepotinib EMA Validation
  553. Digitalization of Production: Merck KGaA, Darmstadt, Germany, and Siemens Collaborate
  554. Merck KGaA, Darmstadt, Germany Announces Partnerships to Advance Materials
  555. Changes in the leadership team of Performance Materials
  556. Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
  557. MilliporeSigma Expands Production Capacities
  558. Bavencio CHMP
  559. CES 2021
  560. FDA Approves TEPMETKO
  561. Merck KGaA, Darmstadt, Germany, Announces Acquisition of AmpTec
  562. Digital-Ethics-Advisory-Panel
  563. Update on the INTR@PID Clinical Program Including Lung 037 Study
  564. Bavencio 1L UC EU Approval
  565. Wolfgang Losert to retire
  566. 2020 State of Curiosity Report
  567. Partnership for elimination of schistosomiasis in Rwanda
  568. MilliporeSigma Continues Commitment to Science Education and Equity
  569. North American Leadership Change in HC
  570. Merck KGaA, Darmstadt, Germany, and BioNTech Extend Strategic Partnership
  571. Purchase of facility in Arizona
  572. Merck KGaA, Darmstadt, Germany, Mourns Hans Joachim Langmann
  573. 2021-02-15 MilliporeSigma Enhances Design for Sustainability Framework, Offers Customers D
  574. Embracing Carers
  575. TINS-Neuroscience
  576. New analysis from the MAGNIFY-MS study on MAVENCLAD® in patients with RMS
  577. MilliporeSigma to Manufacture Next-Generation Biotherapeutics for Alteogen
  578. Merck KGaA, Darmstadt, Germany, Reports Record Results in a Turbulent Year
  579. Xevinapant
  580. Performance Materials Is Now Electronics
  581. New Renewable Energy into the Grid through Virtual Power Purchase Agreement
  582. i350
  583. Reporting Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment
  584. Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Therapies
  585. EMD Electronics Announces Liquid Crystal-Based Solution for Smart Antennas
  586. Merck KGaA, Darmstadt, Germany, Advances ATR Inhibitor Berzosertib in Cell Lung Cancer
  587. Sustainability Report 2020
  588. Merck KGaA, Darmstadt, Germany, and TU Darmstadt Extend Strategic Research Collaboration
  589. EMD Electronics Announces Investment of EUR 20 million to Expand its Site in Shizuoka
  590. Evobrutinib to Demonstrate Reduction of a Key Biomarker
  591. Annual General Meeting: Shareholders Approve all Agenda Items
  592. New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use
  593. Merck KGaA, Darmstadt, Germany Statement on the Out-licensing Agreement
  594. EMD Electronics strengthens business model for Surface Solutions in the Nordics
  595. Merck KGaA, Darmstadt, Germany, raises forecast for full year 2021-04-05-2021
  596. First Quarter of 2021: Great Strength in Challenging Market Environment
  597. Merck KGaA, Darmstadt, Germany Announces Changes in Operating Model for Healthcare
  598. Data Highlight Significant Advances in Cancer Care at ASCO21 for our Oncology Portfolio
  599. Accelerates Scale Up of Lipids
  600. Cultured Meat - Research Grants
  601. Personnel changes to further push science & technology based strategic growth trajectory
  602. Merck KGaA, Darmstadt, Germany, receives Halal certifications
  603. Bioelectronics BBraun Neuroloop
  604. Bioelectronics Inbrain
  605. New Chief Diversity Officer
  606. Investments Darmstadt Site
  607. Future Insight Prize 2021
  608. Manufacturing for new pediatric medication against schistosomiasis
  609. Launch New Green Solvents for Photoresist Removal in Chip Production
  610. Merck KGaA, Darmstadt, Germany, Announces Appointment of Head of China & International ...
  611. Strong Second Quarter with Double-Digit Growth Driven by Big 3
  612. Merck KGaA, Darmstadt, Germany, and TU Darmstadt support visionary sustainability projects
  613. New Statutory Auditor
  614. Changes in the leadership team of Electronics
  615. Company Statement Bintrafusp Alfa
  616. Merck KGaA, Darmstadt, Germany Announces Change in IT Leadership
  617. Capital Markets Day 2021
  618. Smart Antenna
  619. ESMO 2021 Curtain Raiser
  620. Electronics invests in growth
  621. New Group Function Sustainability
  622. Merck KGaA, Darmstadt, Germany, opens second production line for effect pigments
  623. Sabia Schwarzer Appointed Head of Group Communications, Brand and Corporate Affairs
  624. Leadership Changes Group Level
  625. Merck KGaA, Darmstadt, Germany Announces Mutual Decision to End Bintrafusp Alfa Agreement
  626. Enrolment of Evobrutinib Phase III Clinical Trials
  627. MilliporeSigma announces the Licensing of Foundational CRISPR Technology to Cellecta, Pavi
  628. Launch of-Ronacare<sup>®</sup> Epintegrity
  629. New Viral Vector Manufacturing Facility for Gene Therapy
  630. New Real-World MAVENCLAD® Data Show
  631. Evobrutinib-Significant-Reduction-in-Slowly-Expanding-Lesions-in-Patients-with-RMS
  632. Özlem Türeci and Uğur Şahin Inducted into the “Hall of Fame der deutschen Forschung”
  633. Merck KGaA, Darmstadt, Germany, Establishes External Expert Committee for Sustainability
  634. Siemens and Merck KGaA, Darmstadt, Germany, Collaborate to Boost Machine-to-Machine Trust
  635. MilliporeSigma Announces New Innovation & Capacity
  636. Merck KGaA, Darmstadt, Germany, raises forecast for full year 2021
  637. Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth
  638. New Study Identifies Drivers of Scientific Research Productivity
  639. Phase III Results for Arpraziquantel
  640. Merck KGaA, Darmstadt, Germany, Announces New Sector CFO Healthcare
  641. Katherine Dei Cas Appointed to SEMI North America Advisory Board
  642. Novel Mechanisms with the Potential to Transform
  643. First Vaccine Production Facility in Nigeria
  644. Athinia to Accelerate the Use of AI and Big Data to Solve Critical Semiconductor Challenge
  645. EMD Electronics Announces $1 Billion Investment in US to Support Semiconductor Customers
  646. Merck KGaA, Darmstadt, Germany, Expands Corporate Venture Fund M Ventures
  647. Merck KGaA, Darmstadt, Germany, to Lead BAIQO Quantum Computing Project
  648. EMD Electronics at CES 2022 – Advancing Digital Living
  649. Tepmetko receives positive CHMP opinion
  650. Acquisition-of-Chord-Therapeutics
  651. Government Contract Award for New Lateral Flow Membrane Production Facility
  652. Out-licensing Agreement for Osteoarthritis Asset Sprifermin
  653. Definitive Agreement to Acquire Exelead
  654. EMD Electronics Announces New Factory in Arizona
  655. Announcement of New Appointments in Global R&D and Strategy Leadership for Healthcare
  656. Elevian announced as Winner of North American Advance Biotech Grant
  657. 1.5 Billionth Tablet of Praziquantel donated
  658. Launch of new cosmetics ingredients inspired by superfoods
  659. LS-Org-Announcement
  660. Bavencio ASCO GU
  661. Tepmetko-EC-Approval
  662. Acquisition of Exelead Completed
  663. New MAVENCLAD® Data at ACTRIMS Forum 2022
  664. Results of the Fourth Quarter and Fiscal Year 2021
  665. Annual General Meeting: Approval of all Agenda Items
  666. Advances in MS Portfolio
  667. Acquisition of MAST® Platform
  668. Heinrich Emanuel Merck Award 2022
  669. ZooMAb® Antibodies Earns ACT Label
  670. MilliporeSigma Announces Investment of Approximately € 100 Million to Accelerate Single-Us
  671. Science Based Targets initiative
  672. Quarterly Statement Q1/2022
  673. Curiosity Cube® Mobile Lab
  674. Emanuel Merck Lectureship 2022
  675. Investment in Manufacturing Expansion - Cork, Ireland
  676. Merck KGaA, Darmstadt, Germany to Present Latest Research From Oncology Portfolio at ASCO
  677. Development Programs in Oncology
  678. Merck KGaA, Darmstadt, Germany, Places Bonds Amounting to €1.0 billion
  679. Collaboration in Machine Learning Project
  680. Collaboration with Agilent Technologies
  681. CDMO Facility to Address Demand for Critical Cancer Therapies
  682. Q2 2022: Merck KGaA, Darmstadt, Germany, Delivers Robust Growth Despite Headwinds
  683. Future Insight Prize 2022
  684. Modular Automation for Laboratories
  685. Company’s First Lateral Flow Membrane Production Facility in the United States
  686. New Solar Panels at MilliporeSigma’s Wisconsin Site Add Renewable Energy to Power Grid
  687. Collaboration for more sustainable gas solutions
  688. MilliporeSigma Becomes One of the First CDMOs to Provide Full Viral Vector Offering ...
  689. Merck KGaA, Darmstadt, Germany, announces agreement to acquire chemical business of Mecaro
  690. Expansion Molsheim
  691. ESMO 2022 Curtain Raiser
  692. ESMO 2022 Xevinapant
  693. New Chief Human Resources Officer
  694. Biologics Testing Center Shanghai
  695. Nerviano Collaboration
  696. Digital Color Measurement
  697. Millipore CTDMO Services in Martillac
  698. CNote
  699. 2018-04-23 Patent for CRISPR technology in China
  700. Capital Markets Day 2022
  701. "Hall of Fame der deutschen Forschung"
  702. MS Portfolio at ECTRIMS
  703. Digital twin solution for Primary Packaging
  704. New Data for Evobrutinib
  705. Launch new cosmetics ingredients
  706. Quarterly Statement Q3 2022
  707. Biotheus
  708. Merck KGaA, Darmstadt, Germany, Invests € 290 Million in U.S. Drug Safety Testing Capacity
  709. RD Update Call
  710. European Medicines Agency (EMA) Validates Application for Arpraziquantel
  711. MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
  712. MilliporeSigma Signs MoU with Synplogen
  713. EMD Electronics, to showcase technologies and applications at CES 2023
  714. Merck KGaA, Darmstadt, Germany Announces Collaboration with Mersana Therapeutics
  715. Merck KGaA, Darmstadt, Germany, Completes Acquisition of the Chemical Business of Mecaro
  716. Semiconductor Solutions
  717. hc-uc-13-02-2023
  718. EMD Electronics to Showcase Expertise at 2023 SPIE Advanced Lithography & Patterning
  719. Financial results 2022
  720. ACTRIMS Forum 2023
  721. Semiconductor Manufacturing
  722. Merck KGaA, Darmstadt, Germany Announces First Palantir Foundry Open-source Code Library 
  723. Merck KGaA, Darmstadt, Germany, Presents its Latest Cosmetics Innovations
  724. Merck KGaA, Darmstadt, Germany, at the European Coatings Show 2023 in Nuremberg
  725. Merck KGaA, Darmstadt, Germany Strengthens Oncology Franchise
  726. MilliporeSigma Announces Expanded Partnership with Beyond Benign to Increase Global Access
  727. Significant Investment in the World’s Largest Integrated Specialty Gases Facility
  728. Initiation of New Patients on Evobrutinib Paused in the U.S.
  729. MilliporeSigma Launches Ultimus® Film to Offer Superior Strength and Leak Resistance
  730. Curiosity Cube
  731. Annual General Meeting Approves all Agenda Items
  732. Quarterly Statement Q1/2023
  733. Changes in Executive Board
  734. EMD Electronics Expands Renewable Energy Through Virtual Power Purchase Agreement
  735. ASCO 23 Curtain Raiser
  736. Merck KGaA, Darmstadt, Germany’s new barrier materials in OLED devices
  737. MilliporeSigma Increases Commitment to Biosafety Testing With € 35 Million Investment
  738. Merck KGaA, Darmstadt, Germany, Collaborates with Research Groups Based in Berkeley, CA
  739. mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
  740. MilliporeSigma Announces Proteologix as Winner of its North American Advance Biotech Grant
  741. U.S. Businesses of Merck KGaA, Darmstadt, Germany, Named a “Best Place to Work (...)
  742. Future Insight Prize 2023 Awarded to Khalid Salaita for Early Detection of Pandemics
  743. Lenexa, Kansas L3 Expansion PR
  744. Q2 2023: Demonstrating Resilience under Market Pressure
  745. 2023-09-12-Press-Release
  746. Fertility Benefits
  747. AI Partnerships in Healthcare
  748. MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
  749. Embracing Carers UN Collaboration
  750. Merck KGaA, Darmstadt, Germany Releases Its First-Ever DE&I Report
  751. Merck KGaA, Darmstadt, Germany Presents MAVENCLAD® (Cladribine) Tablets Data
  752. Merck KGaA, Darmstadt, Germany Presents New Evobrutinib Data
  753. EMD Electronics Celebrates Opening of New Arizona Factory
  754. Merck KGaA, Darmstadt, Germany to Present Latest Research from Oncology Portfolio at ESMO
  755. Merck KGaA, Darmstadt, Germany, to Return to Growth during Fiscal 2024
  756. Merck KGaA, Darmstadt, Germany, Strengthens Oncology Through Partnership with Hengrui.
  757. VPPAs for Europe
  758. Group Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
  759. MilliporeSigma Launches ChemisTwin™, First Ever Digital Reference Material Platform
  760. Announces Plans for New U.S. Healthcare HQ in Boston
  761. MilliporeSigma Expands Newest Biologics Testing Center in Shanghai
  762. Together with p-Chip we close the gap between physical and digital trust layers
  763. Merck KGaA, Darmstadt, Germany, Strengthens Oncology Portfolio Through Commercialization
  764. AIDDISON™ drug discovery software
  765. Collaboration with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation
  766. Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
  767. EMA’s CHMP Positive for Arpraziquantel to Treat Schistosomiasis in Preschool-Aged Children
  768. EMD Electronics’ material intelligence takes center stage at CES 2024
  769. Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio with Inspirna
  770. Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) as a Standard of Care
  771. Boards of E. Merck KG, Darmstadt, Germany, Newly Elected
  772. Michael Kleinemeier Chairman of our Supervisory Board until the 2024 AGM
  773. Fiscal 2023: Proven resilience during transitional year
  774. The company Invests More Than € 300 Million in New Life Science Production Site in Daejeon
  775. MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafet
  776. MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
  777. Annual General Meeting Elects New Supervisory Board
  778. Merck KGaA, Darmstadt, Germany, Invests More Than € 300 Million in New Life Science Resear
  779. German Federal Minister Robert Habeck visits Merck KGaA, Darmstadt, Germany
  780. Off to a Good Start in Fiscal 2024
  781. Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million
  782. Merck KGaA, Darmstadt, Germany, to Showcase Advances in the Science of Cancer
  783. MilliporeSigma Launches First Software for Complete Data Traceability in Microbial QC
  784. Merck KGaA, Darmstadt, Germany’s Oncology Pipeline Poised to Advance Cancer Treatment
  785. MilliporeSigma Announces Completion of Schnelldorf Distribution Center Expansion
  786. MilliporeSigma Announces € 62 Million Investment in Quality Control Facility in Germany
  787. MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance PD research
  788. Electronics Innovations at Semicon West 2024
  789. Xevinapant Update
  790. Non-Binding MoU with Afrigen Biologics
  791. Future Insight Prize 2024 Awarded to Johns Hopkins University’s Lauren Gardner
  792. Return to Organic Sales Growth
  793. Merck KGaA, Darmstadt, Germany, to Acquire Unity-SC
  794. Merck KGaA, Darmstadt, Germany, to Acquire Unity-SC
  795. Merck KGaA, Darmstadt, Germany Joins German Research Project "Semiconductor-X"
  796. MilliporeSigma Announces Signing of MoU with Gene Therapy Research Institution
  797. Agreement Signed to Sell Surface Solutions Business Unit to GNMI
  798. Merck KGaA, Darmstadt, Germany: Strong 2nd Quarter, Guidance raised
  799. Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
  800. Merck KGaA, Darmstadt, Germany Announces First Patient Dosed in Phase III Study of Oral
  801. MilliporeSigma Receives Industry First EXCiPACT Certification
  802. MilliporeSigma Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing
  803. Merck KGaA, Darmstadt, Germany Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits
  804. Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership
  805. Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership
  806. MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville,Maryland,USA
  1. Our Business Sectors
  2. Life Science
  3. Healthcare
    1. Healthcare Position Statements
    2. Humans of Healthcare
      1. Andree Blaukat & Lisa Benincosa
      2. International Nurses Day 2020: A voice to lead - Nursing the World to Health
      3. Caoimhe Vallely-Gilroy
  4. Electronics
    1. Electronics Glossary
    2. Contact our Electronics team
    3. General Terms and Conditions of Merck KGaA, Darmstadt, Germany
    4. Trademarks
    5. Newsletter subscription
    6. Our commitment to sustainability in the electronics industry
    7. Electronics Business Fundamentals
    8. Information for Suppliers
    9. Sustainability
    10. Culture and Values
    11. Data Analytics and AI
    12. Innovation
    13. Supply Chain Reliability
    14. Materials and Solutions
  5. Vibrant Thoughts Blog
    1. We are in it together for fertility
    2. My Fertility Journey – You are Not Alone
    3. Further hope to save the Northern White Rhino
    4. Leave no one behind
    5. Fertility treatment after 2020
    6. In Oncology, Advancing Targeted Treatment Starts with Testing
    7. Connecting the dots in Fertility
    8. From Challenge Comes Change - International Women´s Day 2021
    9. Patient 360° Summit 2020 Meeting: Innovating Together
    10. Model-Informed Drug Discovery and Development (MID3): Harnessing Knowledge through Collaboration to Inform Decision-Making
    11. Perspective on Addressing the underserved Patient
    12. Precision medicine: cancer genome and beyond
    13. Living a Positive Life with Multiple Sclerosis (MS)
    14. Closing the Care Gap Around the World - World Cancer Day
    15. Insights from the fifth Annual Patient 360° Summit: How can digital Healthcare be improved to better help Patients?
    16. Supporting the Head and Neck Cancer Community, Yesterday, Today and Tomorrow
    17. Hot Topics at ASCO and Beyond: Navigating Key Terms in Medical Oncology
    18. Collaborating with the Head and Neck Cancer Alliance: How Patient Voices Help Drive Our Innovation
    19. 6th Annual Patient 360 Summit providing valuable patient insights on personalised healthcare and clinical trial diversity
    20. WCD 2023: Cancer Doesn’t Care. But We Do.
    21. The Science of Cancer: Helping More Patients Become Survivors
    22. The Science of Cancer: Orchestrating a Holistic Approach to Drug Discovery
    23. Shaping Tomorrow’s Cancer Care Today
    24. Frontiers in Tumor Immunology
    25. Navigating the Waves of Discovery
  6. Emerging Biotech
  7. Environmental Testing
  8. Food and Beverage
    1. Solving Safe. Solving Healthy.
  9. Industrial
  10. Pharma and Biopharma Manufacturing
    1. Accelerating Global Access to Affordable Vaccines
  11. Pharmaceutical Research
    1. The potential of CRISPR technology
    2. Simplifying the CRISPR patent landscape
  12. Clinical and Diagnostics
  13. Government & Academic Research
  14. Cosmetics
    1. Care Solutions
      1. Skin Care
        1. Anti-Aging
        2. Battling the Appearance of Puffiness
        3. Antioxidants
        4. Skin Brightening
        5. Firming
        6. Moisturizing
        7. Skin Improvement
      2. Oral Care
      3. Sun Care
        1. Inorganic UV Filters
        2. Organic UV Filters
        3. Radical Protection
        4. Tanning Agents
      4. Insect Repellent
        1. Insect Repellent IR3535®
        2. Tough on insects
        3. Gentle on you
        4. FAQ
      5. Formulation Support
        1. Antimicrobials Preservatives
        2. Formulation Aids
        3. Formulation Stabilizers
        4. RonaCare® Essential Ingredients
    2. Color Effects
      1. Smart Effect Program
      2. Special Effect Pigments
        1. Black Color Effects
        2. Color Luster Pigments
        3. Color Travel Pigments
        4. Gold Pigments
        5. Interference Pigments
        6. Metallic Color Luster Pigments
        7. Silverwhite Pigments
      3. Functional Fillers
    3. Brands
    4. Services
      1. Application Technology Center
      2. Formulation Examples
      3. Beauty Concepts
        1. Made to Enjoy
        2. Made to Protect
        3. Made to Inspire
        4. All Eyes on Silver
        5. Something to Smile About
        6. Turning Heads
        7. Pearlescence Meets Personal Care
        8. The Root Miracle
        9. Pure Love
        10. 20 Shades of Nude
        11. Not Just On Vacation
        12. Accentuated Eyes
        13. We Value Beauty
        14. Silver Beauty
        15. Fight Against Digital Aging
        16. Polish-up Your Nails
        17. Celebrate Water Saving Formulations
      4. Regulatory Support
      5. Safety
      6. Attestations of Conformity
      7. RonaFlair® Filler Finder
      8. Order your pigment samples
      9. Order your samples
    5. Contact Us
    6. latest
      1. cosmetic-trends
        1. Anti-Pollution
        2. Dermocosmetics
  15. Pharma Quality Control
  16. Fertility
  17. Oncology
  18. Oncology
    1. Head and Neck Cancer*
    2. Colorectal Cancer*
    3. Oncology News Releases
  19. Effect Pigments
    1. Solutions
      1. Coatings
        1. Plastic coatings
        2. Powder coatings
        3. General coating applications
      2. Plastics
        1. Extrusion blow molding
        2. Extrusion
        3. Cast resins
        4. IM3D
        5. Injection molding
        6. Injection stretch blow molding
        7. Latex rubber
        8. WAY Technology
      3. Printing
        1. RGB Printing
        2. VE3D – virtual embossing
        3. Flexo printing
        4. Gravure printing
        5. Offset coating
        6. Screen printing
        7. Photonic Pigments for Colored Solar Modules
      4. Food pigments
        1. Candurin® for Savory
      5. Pharma pigments
        1. Tablet Tool by Candurin®
      6. Automotive
        1. Exterior Effect Pigments
        2. Interior Effect Pigments
      7. Architecture
    2. Brands
    3. Latest
      1. Trends
        1. Global Mobility Color Inspirations
        2. Consumer & Lifestyle Inspirations
        3. Color of the Year
        4. Driving Lifestyle
        5. READY TO STREAM?
      2. Colorstream® Viola Fantasy
      3. Colorstream® Tropic Sunrise
      4. Colorstream® Arctic Fire
      5. Colorstream® Lava Red
      6. Colorstream® Lapis Sunlight
      7. boundless-blue
        1. #8 Serene | Boundless Blue
        2. #1 Cool Steel | Boundless Blue
        3. #2 Adventure | Boundless Blue
        4. #3 Azure | Boundless Blue
        5. #4 Surf's Up | Boundless Blue
        6. #5 Cabrio Blue | Boundless Blue
        7. #6 Free Spirit | Boundless Blue
        8. #7 Aqua Stone | Boundless Blue
    4. Services
      1. Basics of pigment technology
      2. Color cards for print and plastic applications
      3. Color Compendium
      4. The EFFEKTE magazine
      5. Regulatory affairs for effect pigments
      6. Regulatory Affairs for Candurin®
      7. EMD Distributor Resources
      8. Order your samples
      9. TRENDS REPORTS
    5. Contact Us
  20. Display Solutions
    1. Solutions
      1. Liquid crystals
        1. Liquid crystal display (LCD) technologies
          1. Blue Phase LCD technology
          2. In-plane switching (IPS) LCD technology
          3. Multidomain vertical alignment (MVA) LCD technology
          4. Patterned vertical alignment (PVA) technology for LCDs
          5. Twisted nematic (TN) technology for LCDs
          6. Ultra-brightness fringe field switching (UB-FFS) LCD technology
          7. Vertical alignment (VA) technologies for LCD
          8. Polymer stabilized vertical alignment (PS-VA) technology
          9. Self-alignment-Vertical-alignment LCD technology
        2. Liquid crystal phases
        3. The History of LC Displays
      2. Organic light emitting diode (OLED) materials for displays
        1. OLED Display Technology
      3. Reactive mesogens
      4. LED Phosphors
      5. Photoresists
      6. Silazanes for unparalleled protection
      7. Our Flexible Platform
      8. licrivision® Liquid Crystals for Windows
      9. Our Organic Light Emitting Diode (OLED) Solutions
        1. Enhanced displays for advanced applications
        2. Free-form displays –ultimate possibilities
        3. Sustainable OLED solutions
        4. Records in OLED history
        5. Our services at your site
    2. Brands
    3. Latest
      1. 10 Years Ultra-Brightness FFS
    4. Services
    5. Contact Us
    6. Advancing Display
  21. Functional Solutions
    1. More than just Solutions
      1. Empowering Surfaces
        1. Protective coatings for pristine surfaces
          1. Anti-scratch coatings
          2. Corrosion Protection
          3. Easy-to-clean coatings – for surfaces that stay spotless
          4. Adding thermal resistance
        2. Conductive coatings
        3. Heat reflective materials
        4. Optimal Optical coating materials
      2. Simplifying Identification
        1. Product Identification made easy: laser marking
          1. Cable Marking - Hard-wired identification
          2. Film Marking - Follow the Flow
          3. Silicone Marking - Stay flexible
        2. Brand Protection - More than meets the eye
        3. Materials for crystal growth
    2. Brands
    3. Latest
    4. Services
      1. CIRCULAR CREATIVITY SAMPLE
    5. Contact Us
  22. Neurology & Immunology
    1. Multiple Sclerosis
    2. MS Inside Out
      1. Understanding the Importance of HCP-Patient Communication
      2. MS Inside Out means understanding patient needs
        1. Understand Stanca’s Story from the Inside-Out
        2. Understand David’s Story from the Inside-Out
        3. Understand Stephanie’s Story from the Inside-Out
        4. Understand Alfred’s Story from the Inside-Out
        5. Understand Marco’s Story from the Inside-Out
        6. Understand Alexander’s Story from the Inside-Out
        7. Revealing real lives, real stories
      3. MS Inside Out means exploring innovative pathways
        1. Exploring B and T cell crosstalk [1-4]
    3. MS 20/20*
    4. MS Inside Out Documentary
    5. World MS Day
  23. Cardiovascular, Metabolism and Endocrinology
    1. Diabetes
    2. Cardiovascular Diseases
    3. Thyroid Disease
  24. Pharma Biotech
  25. Diagnostics
  26. Academic and Government Research
  27. #Microbiotiful
    1. #Microbiotiful - Belly Button
    2. #Microbiotiful - A handbag
    3. #Microbiotiful - A dog's paw
    4. #Microbiotiful - Nosy ?
    5. #Microbiotiful - A toilet brush
    6. #Microbiotiful - A plastic duck
    7. #Microbiotiful - A toothbrush
    8. #Microbiotiful - A kitchen sponge
  28. Surface Solutions
  29. Semiconductor Solutions
    1. Our Offering
      1. Semiconductor Materials
        1. Thin film solutions
          1. Spin-on Dielectrics
          2. Container return
            1. Customer Return Container Condition Form
        2. Patterning Solutions
        3. Surface Preparation & Cleans
          1. IC Cleans
          2. Litho Cleans
          3. Wet etchants
        4. Specialty Gases
        5. Planarization
        6. Packaging
          1. Interconnects and Conductive Pastes
      2. Delivery Systems & Services
        1. Turnkey Projects and Construction Services
        2. Fab Services
        3. Delivery Systems
          1. GASGUARD® EQUIPMENT
          2. GASGUARD® and CHEMGUARD®
          3. GASGUARD® AP11 Upgrade Options
      3. Product Catalog
      4. Product not available
      5. CHEMGUARD® 1000-2000 Automated Chemical Refill Systems
      6. CHEMGUARD® GEN III BCD 100-200 Bulk Automated Chemical Delivery Systems
      7. CHEMGUARD® Gen III Model CG350 Automated Chemical Refill System W/Opt. eV Heating
      8. CHEMGUARD® GENIII 100-426 Series Automated Chemical Delivery Systems
      9. CHEMGUARD® GENIII 500 Automated Chemical Refill System with Solvent Purge
      10. CHEMGUARD® GENIII CG010 Series Automated Chemical Refill System
      11. CHEMGUARD® GENIII CG050 High Flow Bubbler
      12. CHEMGUARD® GenIII Controller Retrofit
      13. Emergency Response Containment Vessel (ECRV) Model 5503
      14. Emergency Response Containment Vessel Model 5501
      15. Emergency Response Containment Vessel Model 5502
      16. FLOWMASTER® CMP Chemical Delivery System
      17. FLOWMASTER® CMP Slurry Delivery System
      18. FX-30 FOUP FOSB Cleaner
      19. GASGUARD® Acetylene Delivery System
      20. GASGUARD® Active Control Phase 1
      21. GASGUARD® AP11 Controller
      22. GASGUARD® AP11 Controller Auto Recovery/Auto Restart (ARS)
      23. GASGUARD® BULK eV Temperature Control System for Y-Cylinders
      24. GASGUARD® BulkGUARD™ Bulk Gases System
      25. GASGUARD® Distribution Systems VMB-DVB
      26. GASGUARD® eV Temperature Control System
      27. GASGUARD® Gas Delivery Systems
      28. GASGUARD® Hydrogen Chloride Purification System
      29. GASGUARD® LED Lighting – Solid State LED Lighting within the cabinet and controller
      30. GASGUARD® UHP Forming Gas Blender
      31. GASGUARD® Very High Flow System
      32. GCS Global Communications System
      33. Particle-free Ag-ink, ACM-904
      34. Ormet® TLPS, DAP-481-1
      35. Local Trending Software for GASGUARD® AP11/Gen III Controllers
      36. MEGASYS® Services
      37. OMNI™ Quartzware Cleaner
      38. QMAC® Quality Monitoring and Control Analytical System
      39. S-1087 Exhausted Work Station
      40. S-1088 Exhausted Line Rinse Station
      41. S-1702 Etch Parts Cleaner
      42. Turnkey Project Services and Construction Services
      43. TYPHOON™ S790 Quartzware Cleaner
      44. VAPORGUARD® Temperature Control System
      45. Ormet® TLPS, DAP-491-1
      46. Ormet® TLPS, XCAP-823-1
      47. Ormet® TLPS, PCB-710
      48. Dynaflake™ Flake-Form Hot-Melt Polyurethane Cleaner
      49. Dynasolve® Final Prep Precision Cleaning Solvent
      50. Dynalube™ Equipment Storage Fluid
      51. Dynasolve® 100 Cured Urethane and Acrylic Cleaning Solvent
      52. Dynasolve® 180 Cured Polymer Cleaning Solvent
      53. Dynasolve® 185 Amine-Cured Epoxy Cleaning Solvent
      54. Dynasolve® 190A Urethane/Silicone Conformal Coating Removal Solvent
      55. Dynasolve® 200 Series - 218, 220, 225, 230 Cured Silicone Cleaning Solvents
      56. Dynasolve® 2000 Cured Polymer Cleaning Solvent
      57. Dynasolve® 699 Cured Acrylic Cleaning Solvent
      58. Dynasolve® 700 Series - 711, 715, 750, 760 Cured Polymer Cleaning Solvents
      59. Dynasolve® CU-5 Cured Urethane Cleaning Solvent
      60. Dynasolve® CU-6 Urethane Cleaning Solvent
      61. Dynasolve® CU-7 Cured Polyimide Cleaning Solvent
      62. Dynasolve® CU-9 Cured Urethane Cleaning Solvent
      63. Dynasolve® ISO-Neutralizer Liquid Isocyanate Cleaning Solvent
      64. Dynasolve® M-10 Uncured Silicone Flushing Solvent
      65. Dynasolve® M-35 Uncured Epoxy Flushing Solvent
      66. Dynasolve® Mold Cleaner 1000 Urethane Mold Cleaning Solvent
      67. Poly-Flush® Stereolithography (SLA) 3D Printing Cleaning Solvent
      68. PUR-FLUSH 100, 200, and 300 Uncured Urethane Flushing Solvents
      69. UR-AWAY™ FL Uncured Urethane Flushing Solvent
      70. Uresolve™ 411 Urethane Conformal Coating Removal Solvent
      71. ACT® 114
      72. ACT® 273
      73. ACT® 410
      74. ACT® 412
      75. ACT® 690S
      76. ACT® 690SX
      77. ACT® 915A
      78. ACT® 927C
      79. ACT® 930
      80. ACT® 935UP
      81. ACT® 940
      82. ACT® 970
      83. ACT® 970T
      84. ACT® CMIK-S
      85. ACT® CMI-S
      86. ACT® EZStrip® 528H
      87. ACT® NE-111
      88. ACT® NE-14
      89. ACT® NE-89
      90. ACT® XT-1100
      91. BPS-100
      92. BPS-106
      93. BPS-169
      94. BPS-170
      95. BPS-600
      96. BPS-729A
      97. BPS-729B
      98. Dynasolve® 219 Cured Silicone Materials Remover
      99. Dynasolve® FS8320 Semiaqueous Flux Remover for Wafer Level Packaging
      100. Dynasolve® Pi4310 Polyimide Remover
      101. DYNASTRIP® 7700 Multipurpose Photoresist Remover
      102. DYNASTRIP® AP7880T Multipurpose Photoresist Remover
      103. DYNASTRIP® AP7900A Multipurpose Photoresist Remover
      104. DYNASTRIP® AP7900C Multipurpose Photoresist Remover
      105. DYNASTRIP® DL9150 Non-TMAH Multipurpose Photoresist and Post-Etch Residue Remover
      106. DYNASTRIP® DL9150B TMAH-Free Multipurpose Photoresist and Post-Etch Residue Remover
      107. Flipstrip™ Multipurpose Photoresist Remover
      108. NF3 ─ Nitrogen Trifluoride VLSI
      109. C3F8 ─ Octafluoropropane MEGA-CLASS®
      110. ACT® BHP851
      111. AsH3 ─ Arsine ION-X® Dopant Gas Storage and Delivery System
      112. AsH3 ─ Arsine MEGABIT®
      113. AsH3 ─ Arsine MEGABIT® III
      114. BBr3 ─ Boron Tribromide EXTREMA®
      115. CF4 ─ Carbon Tetrafluoride VLSI
      116. ClF3 ─ Chlorine Trifluoride SC
      117. Cl2 ─ Chlorine VLSI
      118. C4F6 ─ Hexafluorobutadiene nCtrl
      119. C4F6 ─ Hexafluorobutadiene VLSI
      120. C2F6 ─ Hexafluoroethane Halocarbon 116
      121. HCl ─ Hydrogen Chloride MEGA
      122. ION-X® BF3 ─ Boron Trifluoride ION-X® Dopant Gas Storage and Delivery System
      123. Xe ─ Xenon
      124. Kr ─ Krypton
      125. C5F8 ─ Octafluorocyclopentene
      126. Phosphine in Argon Mixture
      127. Phosphine in Hydrogen Mixture
      128. ION-X® PH3 ─ Phosphine ION-X® Dopant Gas Storage and Delivery System
      129. PH3 ─ Phosphine MEGABIT® II
      130. PH3 ─ Phosphine MOCVD
      131. POCl3 ─ Phosphorous Oxychloride EXTREMA®
      132. SiCl4 ─ Silicon Tetrachloride
      133. SiF4 ─ Silicon Tetrafluoride VLSI
      134. SF6 ─ Sulfur Hexafluoride
      135. Triethylborate
      136. CO2 ─ Carbon Dioxide MEGABIT®
      137. SiHCl3 ─ Trichlorosilane
      138. NO ─ Nitric Oxide
      139. N2O ─ Nitrous Oxide VLSI
      140. SiH2Cl2 ─ Dichlorosilane
      141. GeH4 ─ Germane
      142. GeH4 ─ Germane Hydrogen Mixture 10%
      143. H2Se ─ Hydrogen Selenide UHP
      144. WF6 ─ Tungsten Hexafluoride Megaclass
      145. WF6 ─ Tungsten Hexafluoride Semiconductor
      146. 10% F2/N2 Mixture ─ AIROPAK® F2/N2 10% Fluorine in Nitrogen Mixture - Commercial Grade
      147. 20% F2/N2 Mixture ─ AIROPAK® F2/N2 20% Fluorine in Nitrogen Mixture - Commercial Grade
      148. D2 ─ Deuterium VLSI
      149. Diborane in Hydrogen Mixture
      150. eF2/N2 (Electronic Grade) 10% Fluorine
      151. eF2/N2 (Electronic Grade) 20% Fluorine
      152. Silica wafer polishing CMP slurries: Syton, Mazin product for Wafer Polishing CMP
      153. Advanced Oxide CMP slurries: STI Selective Oxide CMP, HPD Selective Oxide CMP
      154. Post CMP Cleans
      155. Tungsten CMP slurries
      156. Copper Bulk CMP slurries: Cu Low dishing CMP, Cu High Rate CMP
      157. Copper Barrier CMP slurries: BAR Tunable barrier CMP
      158. SoC
      159. Core resists
      160. KrF Thick film resists
      161. Lift-off Resists
      162. Thick film resists
      163. DSA
      164. TARC
      165. BARC
      166. ArF Rinse
      167. EUV Rinse
      168. Shrink
      169. Developers
      170. Edge Bead Remover (EBR)
      171. BTBAS
      172. 4MS
      173. TEOS
      174. Trimethylsilane
      175. Alpha-Terpinene
      176. Diethoxymethylsilane
      177. CpCo(CO)2
      178. CupraSelect
      179. HFAC
      180. HfCl4 ─ Hafnium tetrachloride
      181. HtB-Octane
      182. Octane
      183. TaCl5
      184. TAETO
      185. TBTDET
      186. TBTEMT
      187. TDEAT
      188. TDEAZr
      189. TDMAHf
      190. TDMAT
      191. TDMAZr
      192. TEMAHf
      193. TEMATi
      194. TMA
      195. WCl5
      196. ZrCl4
      197. CBr4 ─ Carbon tetrabromide
      198. CCl4 ─ Carbon tetrachloride
      199. DEZn
      200. DMZn
      201. TEB
      202. TEG
      203. TMB
      204. TMG
      205. Trans-LC
      206. XeF2 ─ Xenon Difluoride
      207. MoO2Cl2 ─ Molybdenum Dichloride Dioxide
      208. TiCL4 ─ Titanium Tetrachloride
      209. CCTBA
      210. CPMG
      211. PDMAT
      212. TMI
      213. WNBURE
      214. RS series
      215. Spinfil® 600
      216. Spinfil® 800
      217. HC-100
      218. Rinse 500
      219. Thinner 400
      220. C4F8 ─ Octafluorocyclobutane VLSI
      221. C2H2 ─ Acetylene VLSI
      222. C2H2 ─ Acetylene Megaclass
      223. NH3 ─ Ammonia VLSI
      224. BCl3 ─ Boron Trichloride
      225. HCI – SEMI Hydrogen Chloride
      226. Cl2 – Chlorine MEGA
      227. PYRIDINE
      228. Cp-Zr
    2. Industries served
      1. Semiconductor
      2. Polymer Removal Chemistries
      3. Our Customers
    3. Custom Innovation
      1. Intermolecular®
        1. Integrated Solutions
        2. Capabilities
          1. Deposition
          2. Characterization
          3. Fab & Facility
        3. Meet our scientists
          1. Cesar Clavero
          2. Son Hoang
          3. Michael Miller
          4. Navnidhi Upadhyay
          5. Aein Babadi
          6. Runa Koizumi
    4. Digital Solutions
    5. Technical Assets
      1. Glossary
      2. M4Ward™
      3. Delivery System Manuals
      4. Technical presentations
        1. Investing in a Sustainable Semiconductor Future - Materials Matter
        2. Future Ways of Working and Generative AI Disruption
        3. Data and Digital in the Materials World
      5. Technical videos & webinars
      6. Technical articles
    6. How can we help?
      1. Contact Us
      2. Thank you!
  30. Life Science Services
  31. Science and Lab Solutions
  32. Process Solutions
  1. Electronics Product Catalog
    1. Electronics Product Search Results
    2. Electronics Product Documentation
    3. 158121 Xirallic® T61-10 WNT Micro Silver
    4. 158028 Xirallic® T60-10 SW Crystal Silver
    5. 158029 Xirallic® T60-20 SW Sunbeam Gold
    6. 158047 Xirallic® T60-21 SW Solaris Red
    7. 158100 Xirallic® T60-22 WNT Amethyst Dream
    8. 158062 Xirallic® T60-23 SW Galaxy Blue
    9. 158092 Xirallic® T60-25 SW Cosmic Turquoise
    10. 158093 Xirallic® T60-25 WNT Cosmic Turquoise
    11. 158037 Xirallic® T60-24 SW Stellar Green
    12. 158030 Xirallic® F60-50 SW Fireside Copper
    13. 158031 Xirallic® F60-51 SW Radiant Red
    14. 158230 Xirallic® NXT T260-23 SW Tigris Blue
    15. 158225 Xirallic® NXT M260-30 SW Leonis Gold
    16. 158237 Xirallic® NXT F260-51 SW Cougar Red
    17. 141183 Meoxal® F120-30 CWT Taklamakan Gold
    18. 141175 Meoxal® F120-58 CWT Wahiba Orange
    19. 141184 Meoxal® F121-51 CWT Atacama Red
    20. 158108 Pyrisma® T40-27 SW Color Space Indigo
    21. 158114 Pyrisma® T81-23 SW Liquid Blue
    22. 158115 Pyrisma® T81-23 WNT Liquid Blue
    23. 158116 Pyrisma® T40-23 SW Color Space Blue
    24. 158132 Pyrisma® T40-20 SW Color Space Yellow
    25. 158146 Pyrisma® M40-58 SW Ambercup Orange
    26. 141060 Miraval® 95311 WR Scenic White
    27. 158217 Colorstream® F20-51 SW Lava Red
    28. 158015 Colorstream® T20-01 WNT Viola Fantasy
    29. 158090 Colorstream® T20-02 WNT Arctic Fire
    30. 158096 Colorstream® T20-03 WNT Tropic Sunrise
    31. 158103 Colorstream® T20-04 WNT Lapis Sunlight
    32. 140585 Iriodin® 9612 Silver-Grey Fine Satin SW
    33. 104472 Iriodin® 9153 Flash Pearl WR
    34. 104471 Iriodin® 9163 Shimmer Pearl WR
    35. 102933 Iriodin® 9502 Red-Brown SW
    36. 102934 Iriodin® 9504 Red SW
    37. 103551 Iriodin® 9219 Rutile Lilac Pearl SW
    38. 103558 Iriodin® 9507 Scarab Red SW
    39. 104540 Iriodin® 9103 Rutile Sterling Silver SW
    40. 104554 Iriodin® 9605 Blue-Shade Silver SW
    41. 104597 Iriodin® 9225 Rutile Blue Pearl SW
    42. 104598 Iriodin® 9215 Rutile Red Pearl SW
    43. 140500 Iriodin® 97205 Ultra Rutile Platinum Gold SW
    44. 140503 Iriodin® 97215 Ultra Rutile Red Pearl SW
    45. 140504 Iriodin® 97217 Ultra Rutile Copper Pearl SW
    46. 140505 Iriodin® 97219 Ultra Rutile Lilac Pearl SW
    47. 140506 Iriodin® 97225 Ultra Rutile Blue Pearl SW
    48. 140507 Iriodin® 97235 Ultra Rutile Green Pearl SW
    49. 140517 Iriodin® 9235 Rutile Green Pearl SW
    50. 140524 Iriodin® 9602 Silver-Grey SW
    51. 140535 Iriodin® 9205 Rutile Platinum Gold SW
    52. 140539 Iriodin® 9303 Royal Gold SW
    53. 140650 Iriodin® 9307 Star Gold SW
    54. 140540 Iriodin® 9505 Red-Violet SW
    55. 141425 Iriodin® 96107 SW Icy White Lightning
    56. 104319 Iriodin® 9217 Rutile Copper Pearl WR
    57. 104797 Iriodin® 9300 Gold Pearl WR
    58. 104456 Iriodin® 9440 Colibri Blue-Green WR
    59. 104896 Iriodin® 9444 Moss Green WR
    60. 104322 Iriodin® 9500 Bronze WR
    61. 102935 Iriodin® 9524 Red Satin SW
    62. 104542 Iriodin® 9111 Rutile Fine Satin SW
    63. 104543 Iriodin® 9323 Royal Gold Satin SW
    64. 104553 Iriodin® 9525 Red-Violet Satin SW
    65. 104562 Iriodin® 9221 Rutile Fine Blue SW
    66. 104564 Iriodin® 9121 Rutile Lustre Satin SW
    67. 140534 Iriodin® 9201 Rutile Fine Gold SW
    68. 140536 Iriodin® 9211 Rutile Fine Red SW
    69. 140538 Iriodin® 9231 Rutile Fine Green SW
    70. 140543 Iriodin® 9522 Red-Brown Satin SW
    71. 140576 Iriodin® 9119 Polar White SW
    72. 140590 Iriodin® 9223 Rutile Fine Lilac SW
    73. 141081 Iriodin® 9327 Fine Star Gold SW
    74. 104809 Iriodin® 9520 Bronze Satin WR
    75. 104216 Iriodin® 355 Glitter Gold
    76. 106959 Iriodin® 351 Sunny Gold Pearl
    77. 106967 Iriodin® 153 Flash Pearl
    78. 141176 Iriodin® 6153 Icy White Flash
    79. 141107 Miraval® 5401 Royal Twinkle
    80. 140941 Miraval® 5311 Scenic White
    81. 141048 Miraval® 5320 Scenic Gold
    82. 103346 Iriodin® 363 Shimmer Gold
    83. 103977 Iriodin® 249 Flash Gold
    84. 103978 Iriodin® 259 Flash Red
    85. 103985 Iriodin® 289 Flash Blue
    86. 103986 Iriodin® 299 Flash Green
    87. 104234 Iriodin® 530 Glitter Bronze
    88. 104468 Iriodin® 532 Glitter Red-Brown
    89. 104469 Iriodin® 534 Glitter Red
    90. 104246 Iriodin® 103 Rutile Sterling Silver
    91. 106960 Iriodin® 163 Shimmer Pearl
    92. 104235 Iriodin® 502 Red-Brown
    93. 104232 Iriodin® 504 Red
    94. 104231 Iriodin® 500 Bronze
    95. 140994 Colorstream® F10-51 Lava Red
    96. 140962 Colorstream® T10-04 Lapis Sunlight
    97. 140897 Colorstream® T10-03 Tropic Sunrise
    98. 140838 Colorstream® T10-02 Arctic Fire
    99. 140648 Colorstream® T10-01 Viola Fantasy
    100. 141182 Pyrisma® M30-58 Ambercup Orange
    101. 141102 Pyrisma® T30-24 Color Space Green
    102. 141128 Iriodin® 6163 Icy White Shimmer
    103. 140900 Miraval® 5411 Magic White
    104. 141101 Pyrisma® T30-25 Color Space Turquoise
    105. 140902 Miraval® 5411 Magic White KU 28
    106. 140917 Miraval® 5420 Magic Gold
    107. 141100 Pyrisma® T30-23 Color Space Blue
    108. 140918 Miraval® 5421 Magic Copper
    109. 140919 Miraval® 5424 Magic Blue
    110. 140963 Miraval® 5422 Magic Red
    111. 140964 Miraval® 5423 Magic Lilac
    112. 140965 Miraval® 5425 Magic Turquoise
    113. 140966 Miraval® 5426 Magic Green
    114. 141106 Miraval® 5400 Luxury Twinkle
    115. 141116 Miraval® 5402 Pacific Twinkle
    116. 141438 Miraval® 5430 Cosmic Gold
    117. 141442 Miraval® 5450 Cosmic Bronze
    118. 141471 Miraval® 5412 Cosmic Silver
    119. 141099 Pyrisma® T30-27 Color Space Indigo
    120. 140971 Iriodin® 6103 Icy White
    121. 141098 Pyrisma® T30-22 Color Space Violet
    122. 141097 Pyrisma® T30-26 Color Space Magenta
    123. 141096 Pyrisma® T30-21 Color Space Red
    124. 141095 Pyrisma® T30-20 Color Space Yellow
    125. 141415 Iriodin® 6107 Icy White Lightning
    126. 104267 Iriodin® 7235 Ultra Rutile Green Pearl
    127. 104591 Iriodin® 303 Royal Gold
    128. 104634 Iriodin® 300 Gold Pearl
    129. 104670 Iriodin® 100 Silver Pearl
    130. 104898 Iriodin® 600 Black Mica
    131. 104976 Iriodin® 306 Olympic Gold
    132. 106822 Iriodin® Brilliant Pearl KU 26
    133. 140527 Iriodin® 7225 Ultra Rutile Blue Pearl
    134. 140528 Iriodin® 7219 Ultra Rutile Lilac Pearl
    135. 140529 Iriodin® 7205 Ultra Rutile Platinum Gold
    136. 140530 Iriodin® 7217 Ultra Rutile Copper Pearl
    137. 140531 Iriodin® 7215 Ultra Rutile Red Pearl
    138. 140646 Iriodin® 305 Solar Gold
    139. 141056 Pyrisma® T30-00 Pacific Lagoon
    140. 141057 Pyrisma® T30-01 Royal Damask
    141. 104787 Iriodin® 183
    142. 141062 Iriodin® 100 WM 10
    143. 141063 Iriodin® 111 WM 10
    144. 141064 Iriodin® 119 WM 10
    145. 141065 Iriodin® 120 WM 10
    146. 141066 Iriodin® 123 WM 10
    147. 141067 Iriodin® 163 WM 10
    148. 141068 Iriodin® 305 WM 10
    149. 141070 Iriodin® 504 WM 10
    150. 141071 Iriodin® 289 WM 10
    151. 104259 Iriodin® 111 Rutile Fine Satin
    152. 141459 Iriodin® 6111 Icy White Pristine KU26
    153. 103936 Biflair® 66 A
    154. 104611 Biflair® 89
    155. 140583 Biflair® 83 S
    156. 103530 Iriodin® 223 Rutile Fine Lilac
    157. 103947 Iriodin® 211 Rutile Fine Red
    158. 103948 Iriodin® 201 Rutile Fine Gold
    159. 103989 Iriodin® 231 Rutile Fine Green
    160. 104217 Iriodin® 302 Gold Satin
    161. 104236 Iriodin® 520 Bronze Satin
    162. 104237 Iriodin® 522 Red-Brown Satin
    163. 104241 Iriodin® 524 Red Satin
    164. 104470 Iriodin® 221 Rutile Fine Blue
    165. 104590 Iriodin® 323 Royal Gold Satin
    166. 104712 Iriodin® 120 Luster Satin
    167. 104842 Iriodin® 123 Bright Luster Satin
    168. 104869 Iriodin® 326 Olympic Gold Satin
    169. 104959 Iriodin® 119 Polar White
    170. 106823 Iriodin® 119 Polar White KU 26
    171. 106824 Iriodin® 123 Bright Luster Satin KU 26
    172. 141058 Iriodin® 325 Solar Gold Satin
    173. 141113 Iriodin® 119 WAY
    174. 141127 Iriodin® 6123 Icy White Satin
    175. 141465 Spectraval™ Blue
    176. 141466 Spectraval™ White
    177. 141469 Spectraval™ Red
    178. 141470 Spectraval™ Green
    179. 104779 Iriotec® 8830
    180. 104781 Iriotec® 8805
    181. 104782 Iriotec® 8820
    182. 104783 Iriotec® 8825
    183. 104786 Iriotec® 8835
    184. 106825 Iriotec® 8800
    185. 141083 Iriotec® 8208
    186. 141412 Iriotec® 8210
    187. 141414 Iriotec® 8850
    188. 141428 Iriotec® 8815
    189. 141434 Iriotec® 8841
    190. 141467 Iriotec® 8826
    191. 104913 Iriotec® 7320
    192. 140975 Iriotec® 7325
    193. 140990 Iriotec® 7315
    194. 141157 Iriotec® 7330
    195. 141468 Iriotec® 7340
    196. 140700 Iriotec® 9770
    197. 141086 Iriotec® 9880
    198. 141156 Iriotec® 9875
    199. 214042 - DURAZANE® 1033
    200. 214047 - DURAZANE 1066
    201. 214328 - DURAZANE 1085
    202. 214043 DURAZANE 1500 Rapid Cure
    203. 214044 DURAZANE 1500 Slow Cure
    204. 214049 - Durazane® 1800
    205. 585107 Durazane® 2400
    206. 213603 Durazane® 2200
    207. 102125 Calcium Thioglycolate trihydrate
    208. 110152 DHA Plus
    209. 110150 Dihydroxyacetone extra pure for cosmetic purposes
    210. 130165 Emblica®
    211. 105382 Eusolex® 2292
    212. 105844 Eusolex® 9020
    213. 111412 Eusolex® HMS
    214. 105377 Eusolex® OCR
    215. 108898 Zinc sulfide granules sublimed, about 1-4 mm (ZnS) Patinal®
    216. 120606 Candurin® Blue Shimmer
    217. 120617 Candurin® Brown Amber
    218. 120610 Candurin® Gold Lustre
    219. 120608 Candurin® Gold Sheen
    220. 120604 Candurin® Gold Shimmer
    221. 120623 Candurin® Gold Sparkle
    222. 120607 Candurin® Green Shimmer
    223. 120609 Candurin® Light Gold
    224. 120624 Candurin® NXT Ruby Red
    225. 120615 Candurin® Orange Amber
    226. 120613 Candurin® Red Amber
    227. 120619 Candurin® Red Lustre
    228. 120605 Candurin® Red Shimmer
    229. 120622 Candurin® Red Sparkle
    230. 120600 Candurin® Silver Fine
    231. 120602 Candurin® Silver Lustre
    232. 120601 Candurin® Silver Sheen
    233. 120603 Candurin® Silver Sparkle
    234. 117060 RonaFlair® B-50
    235. 117739 RonaFlair® Balance Blue
    236. 117734 RonaFlair® Balance Gold
    237. 117786 RonaFlair® Balance Green
    238. 117732 RonaFlair® Balance Red
    239. 117777 RonaFlair® Boroneige® SF-12
    240. 117778 RonaFlair® Boroneige® SF-15
    241. 117774 RonaFlair® Boroneige® SF-3
    242. 117775 RonaFlair® Boroneige® SF-6
    243. 117776 RonaFlair® Boroneige® SF-9
    244. 117061 RonaFlair® ESQ
    245. 117311 RonaFlair® Extender W
    246. 117022 RonaFlair® Fines
    247. 117789 RonaFlair® Flawless
    248. 117755 RonaFlair® LDP White
    249. 117077 RonaFlair® LF-2000
    250. 117399 RonaFlair® Low Luster Pigment
    251. 104750 RonaFlair® Mica M
    252. 117742 RonaFlair® M-Sphere
    253. 117080 RonaFlair® MTU
    254. 117100 RonaFlair® N-50
    255. 117176 RonaFlair® Silk Mica
    256. 106949 Eusolex® OS
    257. 117756 RonaFlair® Soft Sphere
    258. 117731 RonaFlair® Softshade
    259. 117769 RonaFlair® SynMica M
    260. 117751 RonaFlair® White Sapphire
    261. 105373 Eusolex® T-2000
    262. 105401 Eusolex® T-AQUA
    263. 105335 Eusolex® T-AVO
    264. 117488 Colorona® Amber
    265. 117463 Colorona® Blackstar Blue
    266. 105338 Eusolex® T-EASY
    267. 117460 Colorona® Blackstar Gold
    268. 117464 Colorona® Blackstar Green
    269. 117461 Colorona® Blackstar Red
    270. 117405 Colorona® Bordeaux
    271. 117353 Colorona® Bronze
    272. 117384 Colorona® Bronze Fine
    273. 117376 Colorona® Bronze Sparkle
    274. 117272 Colorona® Carmine Red
    275. 117404 Colorona® Chameleon
    276. 117378 Colorona® Copper
    277. 117385 Colorona® Copper Fine
    278. 117374 Colorona® Copper Sparkle
    279. 111887 IR3535® (Insect repellent 3535) 3-[N-n-butyl-N-acetyl] aminopropionic acid ethylester
    280. 106940 Oxynex® 2004 Cosmetic antioxidant formulation for fats and oils
    281. 117324 Colorona® Dark Blue
    282. 108324 Oxynex® K Liquid Cosmetic antioxidant formulation for fats and oils
    283. 117487 Colorona® Emerald
    284. 132330 Oxynex® L-CV Liquid Cosmetic antioxidant formulation for fats and oils
    285. 132346 Oxynex® LM-CV Cosmetic antioxidant formulation for fats and oils
    286. 117284 Colorona® Fine Gold MP-20
    287. 130217 Oxynex® ST Liquid
    288. 116079 Potassium Thioglycolate Solution About 42% (about 30% thioglycolic acid)
    289. 117050 Colorona® Glitter Bordeaux
    290. 117051 Colorona® Glitter Bronze
    291. 117053 Colorona® Glitter Copper
    292. 117221 Colorona® Gold Plus MP-25
    293. 108885 Zinc sulfide tablets about 1.5 g (ZnS) Patinal®
    294. 108869 Zinc selenide pieces less than 2 cm (ZnSe) Patinal®
    295. 104872 Potassium dihydrogen phosphate Optipur®
    296. 139559 Sodium Iodide Optipur®
    297. 105821 Magnesium fluoride pieces less than 25 mm Optipur®
    298. 116715 Magnesium fluoride pieces
    299. 105689 Lithium fluoride Optipur®
    300. 107386 Lead(II) fluoride Optipur®
    301. 101705 Barium fluoride Optipur®
    302. 800892 - TRIETHYL ORTHOFORMATE FOR SYNTHESIS
    303. 107876 - STRONTIUM HYDROXIDE OCTAHYDRATE PURE
    304. 106453 Sodium hydroxide
    305. 105072 di-Potassium oxalate monohydrate
    306. 139533 Potassium hydroxide
    307. 105949 - MANGANESE(II) NITRATE TETRAHYDRATE
    308. 800891 - ETHYL FORMATE FOR SYNTHESIS
    309. 102534 - COBALT(II) NITRATE HEXAHYDRATE PURE
    310. 101740 - BARIUM PEROXIDE ANHYDROUS HEAVY
    311. 103791 - AMMONIUM IRON(II) SULFATE HEXAHYDRATE EXTRA PURE
    312. 117762 Colorona® Imperial Citrine
    313. 117760 Colorona® Imperial Topaz
    314. 117403 Colorona® Karat Gold MP-24
    315. 117323 Colorona® Light Blue
    316. 117389 Colorona® Magenta
    317. 117190 Colorona® Majestic Green
    318. 117260 Colorona® Mica Black
    319. 117237 Colorona® Beige
    320. 117458 Colorona® Passion Orange
    321. 117490 Colorona® Purple
    322. 117288 Colorona® Patina Gold
    323. 117289 Colorona® Patina Silver
    324. 117322 Colorona® Red Brown
    325. 117320 Colorona® Red Gold
    326. 117271 Colorona® Russet
    327. 117193 Colorona® RY
    328. 117377 Colorona® Sienna
    329. 117386 Colorona® Sienna Fine
    330. 117223 Colorona® Sun Gold Sparkle MP-29
    331. 117782 Colorona® SynBerry Pink
    332. 117757 Colorona® SynBronze
    333. 117761 Colorona® SynCopper
    334. 117754 Colorona® SynCranberry
    335. 117771 Colorona® SynGold
    336. 117089 Colorona® Tangerine Orange
    337. 117489 Colorona® Ochre
    338. 117287 Colorona® Transgold MP-28
    339. 117076 Ronastar® Aqua Sparks
    340. 117716 Ronastar® Blue
    341. 117045 Ronastar® Blue Sparks
    342. 117783 Ronastar® Copper Jewel
    343. 117047 Ronastar® Copper Sparks
    344. 117790 Ronastar® Diamond Black IQ
    345. 117233 Ronastar® Flaming Lights
    346. 132262 RonaCare® 4-Methoxybenzoic Acid
    347. 101015 RonaCare® Allantoin
    348. 117229 Ronastar® Frozen Jewel
    349. 117714 Ronastar® Gold
    350. 117758 Ronastar® Golden Jewel
    351. 101072 RonaCare® Aluminium Chloride Hydroxide Allantoin
    352. 117231 Ronastar® Golden Lights
    353. 130163 RonaCare® AP
    354. 117042 Ronastar® Golden Sparks
    355. 117772 Ronastar® Green Sparks
    356. 110154 RonaCare® ASC III®
    357. 117459 Ronastar® Noble Sparks
    358. 117075 Ronastar® Purple Sparks
    359. 117715 Ronastar® Red
    360. 117472 Ronastar® Red Sparks
    361. 130153 RonaCare® Benzyl Alcohol
    362. 117713 Ronastar® Silver
    363. 130221 RonaCare® Biotin Plus
    364. 117457 Timiron® Arctic Silver
    365. 117266 Timiron® Diamond Cluster MP-149
    366. 117741 Timiron® Glam Silver
    367. 117224 Timiron® Gleamer Flake MP-45
    368. 130170 RonaCare® Bisabolol nat.
    369. 117228 Timiron® Halo White
    370. 117740 Timiron® Ice Crystal
    371. 117021 Timiron® Liquid Silver
    372. 117215 Timiron® Pearl Flake MP-10
    373. 117216 Timiron® Pearl Sheen MP-30
    374. 117241 Timiron® Silk Blue
    375. 117239 Timiron® Silk Gold
    376. 117242 Timiron® Silk Green
    377. 117240 Timiron® Silk Red
    378. 117470 Timiron® Snowflake MP-99
    379. 117476 Timiron® Splendid Blue
    380. 117478 Timiron® Splendid Copper
    381. 117474 Timiron® Splendid Gold
    382. 117477 Timiron® Splendid Green
    383. 117475 Timiron® Splendid Red
    384. 117479 Timiron® Splendid Violet
    385. 117392 Timiron® Starlight Gold
    386. 117383 Timiron® Starlight Red
    387. 117200 Timiron® Starluster MP-115
    388. 117186 Timiron® Super Blue
    389. 116413 Substance H2 granules about 1-4 mm Patinal®
    390. 115591 Substance H4 granules about 0.1-2 mm Patinal®
    391. 109952 Substance M3 granules about 1-4 mm Patinal®
    392. 109941 Substance M2 granules about 1-4 mm Patinal®
    393. 108333 Substance M1 granules
    394. 108332 Substance H4 granules about 1-4 mm Patinal®
    395. 108302 Substance M2 granules about 0.1-2 mm Patinal®
    396. 102437 Substance H4 HD granules about 0.8-4 mm Patinal®
    397. 101835 Substance L5 granules about 1-2 mm Patinal®
    398. 100871 Substance H1 tablets plano-convex, about 6.5 g Patinal®
    399. 100237 Substance H8 granules about 1-4 mm Patinal®
    400. 100231 Substance L5 HD granules about 1-2 mm Patinal®
    401. 100230 Substance H4 HD granules about 0.1-2 mm Patinal®
    402. 116967 Titanium oxide S
    403. 116828 Titanium oxide S granules about 1-4 mm (TiO₁.₇) Patinal®
    404. 116700 Titanium oxide S Pellets (TiO₁.₇) Patinal®
    405. 116440 Yttrium oxide granules about 1-2.5 mm (Y₂O₃) Patinal®
    406. 116011 Aluminium oxide
    407. 115345 Aluminium oxide granules about 1-3 mm (Al₂O₃) Patinal®
    408. 115337 Silicon dioxide granules about 2.5-4 mm (SiO₂) Patinal®
    409. 111771 Titanium(IV) oxide tablets black, about 2 g (TiO₂) Patinal®
    410. 111626 Hafnium(IV) oxide UV granules grey, about 1-4 mm (HfO₂) Patinal®
    411. 111529 Hafnium(IV) oxide UV discs about 6 g (HfO₂) Patinal®
    412. 111480 Zirconium(IV) oxide discs
    413. 110553 Silicon monoxide granules about 4-8 mm (SiO) Patinal®
    414. 110203 Titanium(III) oxide tablets about 1 g (Ti₂O₃) Patinal®
    415. 108907 Zirconium(IV) oxide tablets grey, about 1 g (ZrO₂) Patinal®
    416. 108905 Zirconium(IV) oxide discs grey, about 6 g (ZrO₂) Patinal®
    417. 108902 Zirconium(IV) oxide tablets grey, about 6 g (ZrO₂) Patinal®
    418. 108500 Tantalum(V) oxide granules about 1-4 mm (Ta₂O₅) Patinal®
    419. 108172 Tantalum(V) oxide tablets about 0.5 g (Ta₂O₅) Patinal®
    420. 108044 Silicon dioxide granules about 1-2.5 mm (SiO₂) Patinal®
    421. 107724 Silicon monoxide
    422. 107716 Silicon monoxide granules about 2-4 mm (SiO) Patinal®
    423. 107537 Silicon dioxide granules about 1-4 mm (SiO₂) Patinal®
    424. 117358 Timiron® Super Copper
    425. 117217 Timiron® Super Gold
    426. 117185 Timiron® Super Green
    427. 117187 Timiron® Super Red
    428. 117294 Timiron® Super Silver
    429. 117219 Timiron® Super Silver Fine
    430. 117359 Timiron® Super Violet
    431. 117201 Timiron® Supersheen MP-1001
    432. 117203 Timiron® Supersilk MP-1005
    433. 117764 Timiron® SynBeam Copper
    434. 117763 Timiron® SynBeam Gold
    435. 117765 Timiron® SynBeam Red
    436. 117767 Timiron® SynBeam Violet
    437. 117733 Timiron® Synwhite 40
    438. 117770 Timiron® SynWhite Satin
    439. 117226 Timiron® Ultraluster MP-111
    440. 117165 Xirona® Caribbean Blue
    441. 117499 Xirona® Golden Sky
    442. 117116 Xirona® Kiwi Rose
    443. 117728 Xirona® Le Rouge
    444. 117114 Xirona® Magic Mauve
    445. 117746 Xirona® Moonlight Sparks
    446. 117112 Xirona® Nordic Sunset
    447. 117469 Xirona® Volcanic Fire
    448. 117736 Xirona® Volcanic Sparks
    449. 132722 RonaCare® Zinc Sulfate
    450. 130148 RonaCare® Zinc Oxide
    451. 130201 RonaCare® VTA
    452. 132286 RonaCare® Urea cryst.
    453. 130133 RonaCare® Urea beads
    454. 132386 RonaCare® Tromethamine
    455. 102343 RonaCare® Cetrimonium Bromide
    456. 132120 RonaCare® Sodium Hydroxide
    457. 132398 RonaCare® Cyclopeptide-5 alcoholfree
    458. 132287 RonaCare® Sodium Hydroxide Solution about 32%
    459. 102340 RonaCare® CPC
    460. 132260 RonaCare® Sodium Chloride
    461. 130176 RonaCare® Sodium Benzoate
    462. 130198 RonaCare® Cyclopeptide-5
    463. 132285 RonaCare® Di-Sodium Hydrogen Phosphate
    464. 132261 RonaCare® Salicylic Acid extra pure
    465. 132277 RonaCare® RenouMer
    466. 130200 RonaCare® Ectoin
    467. 132144 RonaCare® Potassium Sorbate
    468. 132232 RonaCare® Potassium Hydroxide
    469. 132149 RonaCare® Poppy SE
    470. 130179 RonaCare® Nicotinamide
    471. 130204 RonaCare® Luremin®
    472. 132318 RonaCare® MAP
    473. 132219 RonaCare® Magnesium Sulfate
    474. 102484 Chromium(III) oxide powder less than 0.3 mm (Cr₂O₃) Patinal®
    475. 101759 Niobium(V) oxide granules
    476. 101058 Aluminium oxide granules about 1-5 mm (Al₂O₃) Patinal®
    477. 100840 Aluminium oxide granules about 1 - 2 mm (Al₂O₃) Patinal®
    478. 111807 Chromium granules about 1-4 mm (Cr) Patinal®
    479. 102486 Chromium
    480. 101502 Silver granules about 1-4 mm (Ag) Patinal®
    481. 115195 Substance WR1 tablets 0.03 Patinal®
    482. 107683 Substance WR1 tablets 0.13 Patinal®
    483. 101822 Substance WR4-SF tablets Patinal®
    484. 115377 Magnesium fluoride
    485. 110261 Magnesium fluoride LO granules about 1-4 mm (MgF₂) Patinal®
    486. 108707 Yttrium fluoride granules less than 1 mm (YF₃) Patinal®
    487. 107388 Lead(II) fluoride
    488. 107014 Gadolinium fluoride granules
    489. 106739 Neodymium fluoride granules about 1-4 mm (NdF₃) Patinal®
    490. 106457 Cryolite granules about 1-4 mm (Na₃AlF₆) Patinal®
    491. 105849 Magnesium fluoride granules about 0.3-1 mm (MgF₂) Patinal®
    492. 105845 Magnesium fluoride granules about 1-4 mm (MgF₂) Patinal®
    493. 105843 Magnesium fluoride
    494. 105834 Magnesium fluoride granules about 2.5-4 mm (MgF₂) Patinal®
    495. 105823 Magnesium fluoride granules about 1-2.5 mm (MgF₂) Patinal®
    496. 102269 Cerium(III) fluoride granules about 1-4 mm (CeF₃) Patinal®
    497. 101601 Ytterbium fluoride granules less than 1.6 mm (YbF₃) Patinal®
    498. 101600 Aluminium fluoride granules about 1-4 mm (AlF₃) Patinal®
    499. 101129 Lanthanum fluoride granules about 1-3 mm (LaF₃) Patinal®
    500. 115031 Black A powder less than 0.3 mm Patinal®
    501. 108322 Substance L5 granules about 0.5-4 mm Patinal®
    502. 140817 Iriotec® 9230
    503. 141499 Iriodin® 96111 SW Icy White Pristine
    504. 107688 Silicon dioxide granules about 1-3 mm (SiO₂) Patinal®
    505. 158069 Xirallic® T50-10 Crystal Silver
    506. 158254 Xirallic® NXT F250-51 Cougar Red
    507. 132354 RonaCare® Malic Acid
    508. 117262 Ronastar® Red Lights
    509. 585110 Durazane® 2800
    510. 158266 Xirallic® NXT M260-70 SW Amur Black
    511. 141600 Meoxal® F120-51 CWT Victoria Red
    512. 141481 Iriodin® 6163 WAY
    513. 117268 RonaFlair® Satin
    514. 158264 Xirallic® NXT T250-23 Tigris Blue
    515. 120625 Candurin® NXT Silver Blossom
    516. 141520 Iriotec® 8855
    517. 132376 RonaCare® Balmance
    518. 141478 Iriodin® 103 WAY
    519. 158241 Xirallic® NXT M250-30 Leonis Gold
    520. 158242 Xirallic® NXT T260-23 WNT Tigris Blue
    521. 117280 Ronastar® Blue Lights
    522. 141530 Biflair® 81
    523. 141535 Iriotec® 8817
    524. 132400 RonaCare® Ectoin IQ
    525. 141547 Lumixir® Solitaire GBM071
    526. 132377 RonaCare® Epintegrity
    527. 102697 High vacuum oil Aneron®
    528. 141541 Iriotec® 7312
    529. 132420 RonaCare® Hibiscus
    530. 132419 RonaCare® Baobab
    531. 117722 Ronastar® Blue Sparks SQ
    532. 132427 Eusolex® Z-BASE
    533. 132428 Eusolex® Z-TEC
    534. 117720 Ronastar® Noble Sparks SQ
    535. 117721 Ronastar® Golden Sparks SQ
    536. 117723 Ronastar® Copper Sparks SQ
    537. 117726 Ronastar® Red Sparks SQ
    538. 117759 Ronastar® Golden Jewel SQ
    539. 117784 Ronastar® Copper Jewel SQ
    540. 130205 Dihydroxymethylchromone
    541. 117286 RonaFlair® Infinity
    542. 117779 RonaFlair® Boroneige® SQ-6
    543. 132429 Eusolex® 232 USC
    544. 494189 1-Ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide No commitment to mass production, for R&D only Solarpur®
    545. 494800 1-Propyl-2,3-dimethyl-imidazolium iodide No commitment to mass production, for R&D only Solarpur®
    546. 117415 Colorona® Treasure Gold
    547. 141549 Iriotec® 8212
    548. Colorstream® F20-52 SW Mineral Red
    549. 117372 Ronaflux® Foxy Red
    550. 117368 Ronaflux® Peacock
    551. 117371 Ronaflux® Specular Green
    552. 117370 Ronaflux® Specular Blue
    553. 117369 Ronaflux® Specular Silver
    554. 132484 RonaCare® Caffeine
    555. 117387 Xirona® Le Coeur
    556. 117282 RonaFlair® Luminous Glow
  1. Our R&D Approach
    1. R&D in Healthcare
      1. Our R&D Areas of Focus
        1. Immunology
        2. Oncology
      2. Our R&D Hubs
      3. Positions & Policies
      4. Clinical Trials
        1. Our Commitment to Responsible Clinical Trial Data Sharing
        2. Our Standard on clinical trial data transparency
    2. R&D in Electronics
    3. R&D in Life Science
  2. Biopharma-Pipeline
  3. Healthcare Pipeline
  4. Global R&D Hubs
  5. Artificial Intelligence - AI Research
    1. Our Team
    2. AI Research
      1. Towards Assumption-free AI
  6. Global Health Institute
    1. Pipeline & Initiatives
    2. The Team
      1. Jutta Reinhard-Rupp
      2. Béatrice Greco
      3. Benjamin Dälken
      4. Claude Oeuvray
      5. Claudia Cecalupo
      6. Delalih Manteau
      7. Jessica Juillard
      8. James Mulry
      9. Rana Afshar
      10. Sophie Magro-Erdös
      11. Thomas Spangenberg
      12. Mireille Gomes
      13. Claudia Demarta-Gatsi
      14. Dr. Joseph Okebe
      15. Sven Lindemann
    3. News
      1. Global Health Collaboration: Development of a new schistosomiasis diagnostic tool
      2. Our company supports healthcare workers fighting Covid-19 in Cameroon
      3. Path to Zero Malaria for prevention and cure of this deadly disease
      4. Artificial Intelligence: Merck KGaA, Darmstadt, Germany, to develop automated Diagnostic Tool for Neglected Tropical Diseases together with Janssen
      5. Global Health in times of Covid-19
      6. World Malaria Day: Zero Malaria Starts With Merck KGaA, Darmstadt, Germany
      7. World Health Day 2020 – Our Global Health Institute supports Nurses and Midwives
      8. Data-driven approach guides our Global Health programs
      9. World Water Day: Access to Clean Water Program
      10. Transmission control as a key component in the fight against schistosomiasis
      11. Merck KGaA, Darmstadt, Germany, actively fights falsified medicines
      12. Merck KGaA, Darmstadt, Germany, as a reliable partner in Global Health
      13. Pediatric Praziquantel Formulation Program: First patient dosed in Phase III clinical trial
      14. We are onboarding an asset against a Neglected Tropical Worm disease from Salvensis and the London school of Hygiene & Tropical Medicine.
      15. Pediatric Praziquantel Consortium: Taking the next step towards access with continued support from the GHIT Fund
      16. Today is World Malaria Day!
      17. We are partnering with FIND to develop a Rapid Diagnostic Test (RDT) for schistosomiasis
      18. Neglected Tropical Diseases: Important dialogues with local communities and experts led by our company
      19. Letter from Jutta Reinhard-Rupp, Head of the Global Health Institute
      20. Consortium Pediatric Praziquantel Program successfully completed Phase II in Ivory Coast
      21. R&D holds 2nd place in the Access to Medicine Index 2018
      22. Global Health Institute contributing to the definition of upcoming Target Product
      23. Our company at International, Scientific Meetings for Global Health
      24. The ESCARGOT Project: Fighting Schistosomiasis through Innovation
      25. Performance Materials: Key Player towards the success of the Consortium Pediatric Praziquantel Program
      26. Hosting African fellows: A Success Story
      27. Merck KGaA, Darmstadt, Germany, played a leading role in Brazil events on schistosomiasis
      28. The Merck KGaA, Darmstadt, Germany, “Power of We” at the service of children suffering from Malaria in Ghana
      29. The International Schistosomiasis Community will celebrate the Global Health Institute in Brazil
      30. Path to Zero Malaria in the front seat at the 7th MIM (Multilateral Initiative on Malaria) Pan-African Malaria Conference
      31. The Global Health Institute presenting at the ‘International Society of Neglected Tropical Diseases (ISNTD) Festival’ in London
      32. The Global Health Institute featured at the 2018 World Health Assembly luncheon on Schistosomiasis
      33. Our company supports the World Malaria Day 2018
      34. The Global Health team represented at the Geneva Health Forum 2018
      35. University of Cape Town and Medicines for Malaria Venture join forces to feed the antimalarial pipeline
      36. The Global Health Institute engages with the Global Health Community
      37. EDCTP and GHIT Fund co-fund the development of the pediatric Praziquantel formulation for schistosomiasis
      38. Joining forces to advocate about Female Genital Schistosomiasis and its impact on HIV